intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
NA,45,102,22,339,1,509
placebo,49,32,13,318,10,422
standard care,11,23,8,101,5,148
hydroxychloroquine,19,20,7,57,14,117
convalescent plasma,10,16,4,73,1,104
questionnaire,6,27,4,62,0,99
blood sample,1,3,0,44,0,48
no intervention,6,5,1,34,0,46
azithromycin,7,4,2,24,3,40
saline,4,0,2,29,0,35
tocilizumab,6,5,0,19,3,33
ivermectin,1,11,1,19,0,32
mesenchymal stem cells,4,4,2,21,0,31
serology test,3,1,3,23,0,30
pcr,4,6,2,17,0,29
remdesivir,5,5,0,16,1,27
ritonavir,1,6,2,17,1,27
favipiravir,4,3,1,18,0,26
prone positioning,2,3,2,18,0,25
lopinavir,1,4,2,16,1,24
chloroquine,1,3,1,14,2,21
lopinavir/ritonavir,1,4,2,13,1,21
control,2,2,0,12,1,17
enoxaparin,0,0,0,16,1,17
heparin,0,2,1,14,0,17
methylprednisolone,2,6,0,9,0,17
oxygen,2,1,0,14,0,17
biological samples,1,1,1,13,0,16
colchicine,0,0,0,15,0,15
exercise,0,5,1,9,0,15
plasma,0,4,1,10,0,15
saliva,1,2,1,11,0,15
interferon,1,4,1,8,0,14
nitazoxanide,0,3,0,11,0,14
survey,2,5,0,7,0,14
vitamin d,2,1,1,10,0,14
dexamethasone,0,2,0,10,1,13
online survey,1,2,2,8,0,13
vitamin c,3,2,1,6,1,13
observational,2,1,0,9,0,12
telehealth,1,3,1,7,0,12
hydroxychloroquine / azithromycin,1,5,2,2,1,11
anakinra,0,0,0,9,1,10
igm/igg rapid test,0,2,2,6,0,10
radiotherapy,1,1,0,8,0,10
ruxolitinib,2,1,0,6,1,10
baricitinib,1,1,0,7,0,9
bcg,3,0,0,6,0,9
ace inhibitor,1,2,1,4,0,8
covid-19,1,1,0,6,0,8
ct-scan,1,2,0,5,0,8
losartan,1,2,0,5,0,8
nitric oxide,1,0,0,7,0,8
zinc,0,1,1,6,0,8
blood test,1,1,0,5,0,7
data collection,0,1,0,6,0,7
lung ultrasound,1,0,1,5,0,7
nasopharyngeal swab,0,1,0,6,0,7
observation,0,2,0,5,0,7
povidone/iodine,0,3,0,4,0,7
rapid test,2,3,1,1,0,7
serum test,0,1,0,6,0,7
best available therapy,0,2,0,4,0,6
camostat mesilate,0,0,0,6,0,6
cholecalciferol,0,0,0,6,0,6
doxycycline,0,2,1,3,0,6
exposure,1,2,0,3,0,6
igg,1,1,1,3,0,6
igg antibody test,0,2,2,2,0,6
interview,1,1,0,4,0,6
ly3819253,1,1,0,4,0,6
mindfulness,0,1,0,5,0,6
oseltamivir,1,0,0,5,0,6
rivaroxaban,0,0,0,6,0,6
sarilumab,2,2,0,1,1,6
ad26.cov2.s,0,0,0,5,0,5
adenovirus type 5 vector,3,0,0,2,0,5
arb,1,0,0,4,0,5
aspirin,0,0,1,4,0,5
best supportive care,0,1,0,4,0,5
chloroquine/hydroxychloroquine,0,0,1,4,0,5
clazakizumab,1,0,0,4,0,5
igm,0,0,1,4,0,5
inactivated sars-cov-2 vaccine,2,0,1,2,0,5
interleukin,1,0,0,4,0,5
nk cells,0,0,0,5,0,5
pulmozyme,0,0,0,5,0,5
quality-of-life assessment,0,0,0,5,0,5
sofosbuvir,0,2,0,3,0,5
telmisartan,0,0,0,5,0,5
therapeutic plasma exchange (tpe),1,2,1,1,0,5
ultrasound,0,1,0,4,0,5
anticoagulation,0,0,0,3,1,4
arbidol,1,1,0,2,0,4
biospeciman collection,0,0,0,4,0,4
biospecimen collection,0,0,0,4,0,4
bnt162b2,2,0,0,2,0,4
bromhexine hydrochloride,1,1,1,1,0,4
budesonide,1,0,0,3,0,4
gam-covid-vac,1,1,0,2,0,4
igm antibodytest,0,2,0,2,0,4
immunoglobulin,0,1,0,3,0,4
lenzilumab,1,0,0,3,0,4
low,1,0,0,3,0,4
mask,0,2,0,2,0,4
mavrilimumab,1,0,0,3,0,4
melatonin,1,0,0,3,0,4
na-831,0,0,2,2,0,4
peginterferon,1,0,1,2,0,4
regn10933,0,0,0,4,0,4
regn10987,0,0,0,4,0,4
ribavirin,0,1,0,3,0,4
supportive care,1,1,0,2,0,4
,1,1,1,0,0,3
acalabrutinib,2,0,0,1,0,3
antibody test,0,0,0,3,0,3
behavior,1,0,0,2,0,3
biological,0,0,0,3,0,3
blood,0,0,0,3,0,3
blood donation sms,0,1,2,0,0,3
bnt162b1,1,0,0,2,0,3
canakinumab,2,0,0,1,0,3
cenicriviroc,0,0,0,3,0,3
chadox1,2,0,0,1,0,3
chest ct,0,2,0,1,0,3
ciclesonide,0,0,0,3,0,3
clinical assessment,0,2,0,1,0,3
clinical data,2,0,0,1,0,3
clopidogrel,0,1,0,2,0,3
corticosteroid,0,0,0,3,0,3
coviage,0,3,0,0,0,3
covid-19 pandemic,1,1,0,1,0,3
cyclosporine,0,0,0,3,0,3
cytokine adsorption,0,0,0,3,0,3
cytosorb,0,0,0,3,0,3
daclatasvir,0,0,0,3,0,3
data record,0,0,0,3,0,3
ecg,0,0,0,3,0,3
echocardiography,0,2,0,1,0,3
education,0,1,1,1,0,3
eidd-2801,0,1,0,2,0,3
famotidine,0,1,0,2,0,3
high flow nasal cannula,0,1,0,2,0,3
information,0,0,2,1,0,3
mesenchymalÂ stem cells,0,0,0,3,0,3
mrna-1273,3,0,0,0,0,3
nafamostat mesilate,0,0,0,3,0,3
nasal,0,0,0,3,0,3
nasal rinse,0,0,0,3,0,3
niclosamide,0,0,0,3,0,3
nigella sativa,0,1,0,2,0,3
non-interventional,0,0,0,3,0,3
opaganib,1,1,0,1,0,3
other,0,1,0,2,0,3
pcr/serology,0,0,0,3,0,3
prednisone,0,1,0,1,1,3
probiotic,0,0,0,3,0,3
sample collection,0,0,0,3,0,3
sampling,0,0,0,3,0,3
sargramostim,0,0,0,3,0,3
sars-cov-2 rs,1,0,0,2,0,3
sevoflurane,0,0,0,3,0,3
sodium,0,0,0,3,0,3
taste,0,0,0,3,0,3
throat swab,0,1,0,2,0,3
thromboprophylaxis,0,1,0,2,0,3
vitamin super b-complex,0,0,0,3,0,3
vpm1002,1,0,0,2,0,3
vv-ecmo,0,1,0,2,0,3
yoga,0,0,0,3,0,3
28-day schedule,0,0,1,1,0,2
abatacept,0,0,0,2,0,2
acetylsalicylic acid,0,1,0,1,0,2
adjuvant,1,0,0,1,0,2
aeonose,0,2,0,0,0,2
allocetra-ots,1,0,0,1,0,2
antibiotics,0,1,0,1,0,2
antihypertensives,1,0,0,1,0,2
assessment of work-related stress,0,1,0,1,0,2
atazanavir,0,0,0,2,0,2
atorvastatin,0,0,0,2,0,2
ayurveda,0,2,0,0,0,2
azd1222,0,0,0,2,0,2
bacille calmette-guã©rin (bcg),0,0,0,2,0,2
bcg-denmark,0,0,0,2,0,2
behavioral,0,0,1,1,0,2
bevacizumab,0,1,0,1,0,2
biological data,2,0,0,0,0,2
blood draw,0,0,0,2,0,2
breath test,0,0,0,2,0,2
brequinar,0,0,0,2,0,2
camostat,0,0,0,2,0,2
cannabidiol,2,0,0,0,0,2
cardiac,0,1,0,1,0,2
cardiac/electrodermal recordings,0,1,0,1,0,2
cellectraâ® 2000,1,0,0,1,0,2
clinical examination,0,0,0,2,0,2
cobicistat,0,0,0,2,0,2
conjunctival swab,0,1,0,1,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",0,0,0,2,0,2
corticosteroids,1,0,0,1,0,2
covid-19 patients,0,0,0,2,0,2
cpap,0,0,0,2,0,2
ct-p59,1,0,0,1,0,2
cumin,0,1,0,1,0,2
dalteparin,0,2,0,0,0,2
dapagliflozin,0,0,0,2,0,2
darunavir,0,0,0,2,0,2
darunavir/cobicistat,0,0,0,2,0,2
defibrotide,0,0,0,2,0,2
diagnostic test,0,1,0,1,0,2
dialysis,1,0,0,1,0,2
dipyridamole,0,0,0,2,0,2
dornase alfa,0,1,0,1,0,2
edp1815,0,0,0,2,0,2
electrodermal recordings,0,1,0,1,0,2
elisa,1,1,0,0,0,2
emotional stimulation,0,1,0,1,0,2
emtricitabine,0,0,0,2,0,2
exo 1 inhalation,0,1,1,0,0,2
exo 2 inhalation,0,1,1,0,0,2
expressive writing,0,2,0,0,0,2
favipiravir/hydroxychloroquine,0,0,0,2,0,2
file scanning,0,0,0,2,0,2
flow cytometry,0,0,0,2,0,2
fondaparinux,0,2,0,0,0,2
fostamatinib,0,0,0,2,0,2
fuzheng huayu,0,1,0,1,0,2
guduchi ghan vati,0,2,0,0,0,2
honey,0,1,0,1,0,2
hormones,1,0,0,1,0,2
human amniotic fluid,0,0,0,2,0,2
hyperbaric oxygen,0,0,0,1,1,2
ibrutinib,0,0,0,2,0,2
ibuprofen,0,0,0,2,0,2
icu treatment,0,0,0,2,0,2
igg test,0,1,0,1,0,2
iloprost,0,0,0,2,0,2
imatinib,0,0,0,2,0,2
imu-838,0,0,0,2,0,2
infliximab,0,0,0,2,0,2
ino-4800,1,0,0,1,0,2
iodine,0,0,0,2,0,2
kb109,0,0,0,2,0,2
kb109 / self supportive care (ssc),0,0,0,2,0,2
kg,1,0,0,1,0,2
l-citrulline,0,0,0,2,0,2
ledipasvir,0,2,0,0,0,2
ly3832479,0,0,0,2,0,2
"magpro x100 stimulator, b70 fluid-cooled coil",0,0,0,2,0,2
maraviroc,0,0,0,2,0,2
mechanical ventilation,0,0,0,2,0,2
meditation,0,0,1,1,0,2
meditation (1 x 20-minute guided audio training),0,0,0,2,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-,0,0,1,1,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,0,0,1,1,0,2
mefloquine,2,0,0,0,0,2
menacwy,1,0,0,1,0,2
molnupiravir,0,0,0,2,0,2
mri,0,0,0,2,0,2
muscle,1,0,0,1,0,2
n-acetylcysteine,0,0,0,2,0,2
nasopharyngeal swabs,0,0,0,2,0,2
news,0,1,0,0,1,2
nigella sativa / black cumin,0,1,0,1,0,2
nutrition,1,0,0,1,0,2
octagam,1,0,0,1,0,2
omega-3,0,0,0,2,0,2
online questionnaires,0,1,0,1,0,2
online support group,1,0,0,1,0,2
ophthalmologic exam,0,1,0,1,0,2
oral polio vaccine,0,0,2,0,0,2
paracetamol,1,0,0,1,0,2
phone call,0,0,0,2,0,2
physical therapy,1,0,0,1,0,2
physiotherapy,0,1,0,1,0,2
pirfenidone,0,0,0,2,0,2
plx-pad,0,0,0,2,0,2
povidone-iodine,0,0,0,2,0,2
practice details,0,2,0,0,0,2
prayer,0,0,0,2,0,2
pregnant women with laboratory-confirmed 2019-n-cov,0,0,0,2,0,2
preventive information,0,0,2,0,0,2
psychological,1,0,0,1,0,2
pul-042,0,0,0,2,0,2
pulmonary rehabilitation,0,1,0,1,0,2
pyronaridine-artesunate,0,0,0,2,0,2
quality of life,0,0,1,1,0,2
quercetin,0,0,0,2,0,2
radiological,0,0,0,2,0,2
ravulizumab,0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cell) low-dose group,0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cells) high-dose group,0,0,0,2,0,2
recop unit patient,1,1,0,0,0,2
regn10933 / regn10987,0,0,0,2,0,2
regn10933/regn10987 combination therapy,0,0,0,2,0,2
rtb101,0,0,0,2,0,2
sars-cov-2,0,1,0,1,0,2
sars-cov-2 rs/matrix-m1 adjuvant,1,0,0,1,0,2
self supportive care (ssc),0,0,0,2,0,2
self supportive care (ssc) alone,0,0,0,2,0,2
semi-directive interview,0,0,0,2,0,2
siltuximab,0,0,0,2,0,2
simple cognitive task intervention,0,0,0,2,0,2
sirolimus,0,0,0,2,0,2
sivomixx,1,0,0,1,0,2
soc / placebo,0,0,0,2,0,2
sodium bicarbonate,1,0,0,1,0,2
sofosbuvir/ledipasvir,0,2,0,0,0,2
spirometry,0,0,0,2,0,2
stool collection,0,1,0,1,0,2
td-0903,0,1,0,1,0,2
tele-yoga,0,2,0,0,0,2
tinzaparin,0,2,0,0,0,2
tinzaparin/dalteparin,0,2,0,0,0,2
tofacitinib,0,0,0,2,0,2
traditional chinese medicine,0,0,0,2,0,2
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,1,0,2
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,1,0,2
ultrasonography,0,1,0,1,0,2
v,0,0,1,1,0,2
volatile organic compounds analysis,0,0,0,2,0,2
vv-ecmo / cytokine adsorption,0,0,0,2,0,2
water,0,1,0,0,1,2
whole exome sequencing,0,0,0,2,0,2
- tocilizumab,1,0,0,0,0,1
-interferon nebulization,0,1,0,0,0,1
"""calm"" is a mindfulness meditation mobile app",0,1,0,0,0,1
": igg, ig m serologies in the amniotoc fluid, the blood cord",0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet,0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet/ct,0,0,0,1,0,1
[timp-2]*[igfbp-7],0,1,0,0,0,1
0.12% chg oral rinse,0,0,0,1,0,1
0.12% chlorhexidine gluconate mouth rinse,0,0,0,1,0,1
0.4ml inj syringe 0.4ml,0,0,0,1,0,1
0.5% povidone iodine,0,0,0,1,0,1
0.9% normal saline,0,0,0,1,0,1
1% hydrogen peroxide,0,0,0,1,0,1
10 to 14 days later,0,0,0,1,0,1
100 mg,0,0,0,1,0,1
1200 mg),0,0,0,1,0,1
14-day schedule,0,0,0,1,0,1
1600 mg),0,0,0,1,0,1
18f-î±vî²6-bp,0,0,1,0,0,1
2.2x10^10vp (qpcr) boost,0,0,0,1,0,1
21 - phase 2,1,0,0,0,0,1
24 hour holter ecg,0,0,0,1,0,1
3),0,0,0,0,1,1
40-steps-test,0,0,0,1,0,1
40ml blood sample,0,0,1,0,0,1
4plants,0,0,1,0,0,1
4plants/azythromycin,0,0,1,0,0,1
6 months later,0,0,0,1,0,1
6 weeks after delivery,0,0,0,1,0,1
600mg) oral suspension,0,0,0,1,0,1
a short video intervention,0,0,0,1,0,1
a vignette intervention,0,0,0,1,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level",0,0,1,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",0,0,1,0,0,1
aã§aã­ palm berry extract - natural product,0,0,0,1,0,1
aapc,0,0,0,1,0,1
aaz covid-19 rapid test,0,0,0,1,0,1
abdominal ultrasound,0,1,0,0,0,1
abivertinib,0,0,0,1,0,1
abpm,0,0,0,1,0,1
abx464,0,0,0,1,0,1
accuchek inform ii platform,0,0,0,1,0,1
"ace inhibitor, angiotensin receptor blocker",0,0,0,1,0,1
ace inhibitor/arb,1,0,0,0,0,1
ace inhibitors/calcium channel blockers,0,1,0,0,0,1
ace/arb,0,0,0,1,0,1
acknowledgement racial injustice ama,1,0,0,0,0,1
actigraphy,0,0,0,1,0,1
action (tara),0,1,0,0,0,1
activase,0,0,0,1,0,1
active comparator,0,0,0,1,0,1
active control:healthy living,1,0,0,0,0,1
active covid-19 disease,0,0,0,1,0,1
activity,0,1,0,0,0,1
acute kidney injury,0,1,0,0,0,1
ad5-ncov,0,0,0,1,0,1
adam sensor,0,0,0,1,0,1
adaptation at work score (psas),0,1,0,0,0,1
"adaptive immune response, complement activation,",0,0,0,1,0,1
adenovirus type-5 vectored covid-19 vaccine,1,0,0,0,0,1
adimrsc-2f,0,0,0,1,0,1
administration of equine immunoglobulin anti sars-cov-2,1,0,0,0,0,1
admission to icu for covid-19,0,1,0,0,0,1
adsorbed covid-19 (inactivated) vaccine,0,0,0,1,0,1
aerobic training,0,0,0,1,0,1
aerosolized dnase,0,0,0,1,0,1
african american sender acknowledgement,1,0,0,0,0,1
african american sender in informational videos.,1,0,0,0,0,1
after-each-case room disinfection,0,1,0,0,0,1
after covid-19 pandemic,0,0,0,1,0,1
after the covid-19 outbreak in patients with behã§et,0,0,1,0,0,1
ag0301-covid19,1,0,0,0,0,1
ag0302-covid19,1,0,0,0,0,1
agent-797,0,0,0,1,0,1
ai algorithm,0,0,0,1,0,1
ai model,1,0,0,0,0,1
airwave oscillometry,0,0,0,1,0,1
airway management during sedation,0,0,0,1,0,1
airway management during sedation/general anesthesia,0,0,0,1,0,1
airway pressure release ventilation,0,1,0,0,0,1
ak119,0,0,0,1,0,1
albumine,0,0,0,1,0,1
alexa amazon,0,0,0,1,0,1
all treatment about covid-2019,0,0,0,1,0,1
allogeneic,0,0,0,1,0,1
almitrine,0,0,0,1,0,1
alpha one antitrypsin,0,0,0,1,0,1
alum adjuvant,0,0,0,1,0,1
aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
alvelestat,0,0,0,1,0,1
alveolar,0,0,0,1,0,1
ama acknowledgement drug pricing,1,0,0,0,0,1
ambrisentan,0,0,0,1,0,1
ambulation,0,0,0,1,0,1
amiodarone,0,0,0,1,0,1
amlodipine,0,0,0,1,0,1
ampion,1,0,0,0,0,1
an69-oxiris,0,0,0,1,0,1
an69-standard,0,0,0,1,0,1
anakinra/ruxolitinib,0,0,0,0,1,1
"analysis of cytokine response, innate",0,0,0,1,0,1
"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",0,0,0,1,0,1
ang-3777,0,0,0,1,0,1
anger message,0,1,0,0,0,1
angiogenic biomarkers,0,0,0,1,0,1
angiography scanner,0,0,0,1,0,1
angiotensin-(1-7),0,0,0,1,0,1
angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),0,1,0,0,0,1
angiotensin ii,0,0,0,1,0,1
angiotensin peptide (1-7) derived plasma,0,0,0,1,0,1
anise,0,0,0,1,0,1
anluohuaxian,0,0,0,1,0,1
anne one,0,0,1,0,0,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,0,0,0,1,0,1
anti-sars-cov-2 igt seropositivity,0,1,0,0,0,1
anti-sars-cov-2 igy,0,0,0,1,0,1
anti-sars-cov2 serological controls,0,0,0,1,0,1
anti-sars-cov2 serological controls/serum neutralization,0,0,0,1,0,1
anticoagulation agents (edoxaban and,0,0,0,1,0,1
anticoagulation agents (edoxaban and/or high dose lmwh),0,0,0,1,0,1
antidiabetic treatment,0,1,0,0,0,1
antioxidants,0,0,0,1,0,1
antirheumatic drugs,0,0,1,0,0,1
antithrombotic therapy (anticoagulant and,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,0,1,0,0,0,1
antroquinonol,0,0,0,1,0,1
anxiety,0,0,0,1,0,1
anxiety questionnaire,0,0,0,1,0,1
anxiety reduction training,0,0,0,1,0,1
anxiety),0,0,0,1,0,1
any drug used to treat covid-19,0,0,0,1,0,1
apilimod dimesylate,0,0,0,1,0,1
apixaban,0,0,0,1,0,1
apixaban 2.5 mg,0,0,0,1,0,1
apixaban 5mg,0,0,0,1,0,1
apl-9,0,0,0,1,0,1
appendectomy,0,1,0,0,0,1
apple watch,0,0,0,1,0,1
apps,0,0,0,1,0,1
apremilast,0,0,0,1,0,1
aprepitant injectable emulsion,0,0,0,1,0,1
aprotinin,1,0,0,0,0,1
arb blocker,0,1,0,0,0,1
arbidol hydrochloride/interferon atomization,0,0,0,1,0,1
arct-021 dose 1,0,0,0,1,0,1
arct-021 dose 2,0,0,0,1,0,1
arct-021 dose 3,0,0,0,1,0,1
arct-021 dose 4,0,0,0,1,0,1
arct-021 dose regimen 1,0,0,0,1,0,1
arct-021 dose regimen 2,0,0,0,1,0,1
ardsnet,0,0,0,1,0,1
argatroban,0,0,0,1,0,1
artemesia annua,0,0,0,1,0,1
artemic,0,0,0,1,0,1
artemisia annua leaf,0,0,0,1,0,1
artesunate,0,0,0,1,0,1
artesunate-amodiaquine,0,0,0,1,0,1
asbrip,0,0,0,1,0,1
asc09,0,0,0,1,0,1
asc09f/oseltamivir,0,0,0,1,0,1
ascorbic acid/zinc gluconate,0,0,1,0,0,1
aspirin 25mg orally,0,0,0,1,0,1
assembled mask,0,0,0,1,0,1
assessing impact of covid19,0,0,1,0,0,1
assessment of cardiovascular diseases,0,0,0,1,0,1
assessment of cardiovascular diseases/cardiovascular risk factors,0,0,0,1,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4,0,0,0,1,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,0,0,0,1,0,1
assessment of the sequelae after hospitalization for sars-cov-2,0,0,1,0,0,1
assessment of ventilator-associated pneumonia criteria,0,0,0,1,0,1
assessment tests,0,0,0,1,0,1
assessment),0,0,0,1,0,1
assigned strategies: active choice,0,0,0,1,0,1
assigned strategies: enhanced active choice,0,0,0,1,0,1
assigned strategies: opt-in,0,0,0,1,0,1
asunercept,0,0,0,1,0,1
asynchronies detection,0,1,0,0,0,1
at-001,0,0,0,1,0,1
at-527,0,0,0,1,0,1
at risk for covid-19 infection,0,0,0,1,0,1
atazanavir/dexamethasone,0,0,0,1,0,1
ati-450,0,0,0,1,0,1
atovaquone,0,0,0,1,0,1
atovaquone/azithromycin,0,0,0,1,0,1
attendance by ambulance crew,0,0,0,1,0,1
attention bias modification (abm),0,1,0,0,0,1
atyr1923,1,0,0,0,0,1
audio-visual triage system (avt),0,1,0,0,0,1
auditory evoked potentials (aep),0,0,0,1,0,1
auricular neuromodulation,0,0,0,1,0,1
auricular percutaneous neurostimulation,0,0,0,1,0,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),0,1,0,0,0,1
autopsy,0,1,0,0,0,1
auxora,0,0,0,1,0,1
avdoralimab,0,0,0,1,0,1
avigan,0,0,0,1,0,1
aviptadil,0,0,0,1,0,1
aviptadil/standard care,0,0,0,1,0,1
award,0,0,0,1,0,1
award advice,0,0,0,1,0,1
award/covid-specific advice,0,0,0,1,0,1
ayurvedic kadha,0,1,0,0,0,1
azd1656,0,0,0,1,0,1
azd7442,1,0,0,0,0,1
azoximer bromide,0,0,0,1,0,1
bactek-r,0,0,0,1,0,1
bactrl-spike,0,0,0,1,0,1
bandebereho fathers',0,0,1,0,0,1
bardoxolone methyl,0,0,0,1,0,1
bariatric procedures,0,0,0,1,0,1
baricitinib/anakinra,0,0,0,1,0,1
baseline,0,0,0,1,0,1
baseline blood sample,0,0,0,1,0,1
baseline message,0,1,0,0,0,1
baseline/during hospitalization blood samples,0,0,0,1,0,1
basic feedback,1,0,0,0,0,1
bbv152,0,0,0,1,0,1
bbv152a - phase i,1,0,0,0,0,1
bbv152a - phase ii,1,0,0,0,0,1
bbv152b - phase i,1,0,0,0,0,1
bbv152b - phase ii,1,0,0,0,0,1
bbv152c - phase i,1,0,0,0,0,1
bdb-001 injection,0,0,0,1,0,1
beck depression inventory (bdi),0,1,0,0,0,1
behavioral activation ssi,0,0,0,1,0,1
behaviour change technique intervention to improve quality of life,0,0,0,1,0,1
bemiparin,0,0,0,1,0,1
bemiparin sodium,0,0,0,1,0,1
bempegaldesleukin,0,0,0,1,0,1
berberine,0,1,0,0,0,1
best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
beta interferon,0,0,0,1,0,1
bgb dxp593,0,0,0,1,0,1
bi 764198,0,0,0,1,0,1
bicalutamide 150 mg oral tablet,0,0,0,1,0,1
bidirectional oxygenation mouthpiece,0,0,0,1,0,1
bio 300 oral suspension,0,0,0,1,0,1
bio101,0,0,0,1,0,1
biochemical analysis,0,1,0,0,0,1
biological assays in particular on the lipid metabolism,0,1,0,0,0,1
biological sample/clinical data collection,0,0,0,1,0,1
biological test,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,0,0,0,1,0,1
"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",0,0,0,1,0,1
biomarkers expression,0,0,0,1,0,1
biosensor,0,0,0,1,0,1
biovitals,0,0,0,1,0,1
bivalirudin,0,0,0,1,0,1
bld-2660,1,0,0,0,0,1
blink,0,0,0,1,0,1
blink/masseter inhibitory reflex,0,0,0,1,0,1
blood collection on their first consultation/10 to 14 days later,0,0,0,1,0,1
blood d-dimer assay,0,1,0,0,0,1
blood group determination,0,0,0,1,0,1
"blood tests sputum, nasal lavage",0,0,0,1,0,1
"blood tests sputum, nasal lavage/brushing",0,0,0,1,0,1
blood/derivatives,0,0,0,1,0,1
bloodwork,0,0,0,1,0,1
bms-986253,0,0,0,1,0,1
bnt162a1,0,0,0,1,0,1
bnt162b3,0,0,0,1,0,1
bnt162c2,0,0,0,1,0,1
boost,0,0,0,1,0,1
bovhyaluronidase azoxymer,0,0,0,1,0,1
brain mri,0,0,0,1,0,1
brazilian green propolis extract (epp-af),0,1,0,0,0,1
breath biopsy,0,0,0,1,0,1
breath biopsy face masks with removable filters,0,0,0,1,0,1
breath biopsy face masks with removable filters/fitted pva strip,0,0,0,1,0,1
breath test/cheek swab,0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",0,0,0,1,0,1
bridge therapy,0,0,0,1,0,1
brief interpersonal telepsychotherapy,0,0,1,0,0,1
brief psychiatric rating scale,0,0,0,1,0,1
bromelain,0,0,0,1,0,1
bromhexine oral tablet and/or hydroxychloroquine tablet,0,0,0,1,0,1
broncho-vaxomâ®,0,0,0,1,0,1
brushing,0,0,0,1,0,1
btl-tml-covid,0,0,0,1,0,1
bucillamine,0,0,1,0,0,1
building of the classification model,0,0,0,1,0,1
burnout,0,0,0,1,0,1
butterfly,0,0,0,1,0,1
butterfly iq,0,0,0,1,0,1
bva-100,0,0,0,1,0,1
by computer consultation,0,1,0,0,0,1
c-reactive protein,0,0,0,1,0,1
c21,0,1,0,0,0,1
c3,0,1,0,0,0,1
c3/ holter monitor,0,1,0,0,0,1
cag,0,0,0,1,0,1
calcium channel blockers,0,1,0,0,0,1
cambridge validated viral detection,0,0,0,1,0,1
candesartan,0,0,0,1,0,1
canine odor detection of volatile organic compounds,0,0,0,1,0,1
cap-1002,0,0,0,1,0,1
capillary collection,0,0,0,1,0,1
capillary collection/testing,0,0,0,1,0,1
cardiac ct,0,0,0,1,0,1
cardiac mri,0,0,0,1,0,1
cardiac surgery,0,0,0,1,0,1
cardiology clinical consultations,0,0,0,1,0,1
cardiopulmonary resuscitation,0,1,0,0,0,1
cardiovascular risk factors,0,0,0,1,0,1
care as usual,0,0,1,0,0,1
care modalities,0,1,0,0,0,1
caring contacts,0,0,0,1,0,1
carotid artery reactivity testing,1,0,0,0,0,1
case fatality rate,0,1,0,0,0,1
cash transfer,1,0,0,0,0,1
castem,0,0,0,1,0,1
ccp,0,0,0,1,0,1
cd24fc,1,0,0,0,0,1
cell therapy protocol 1,0,0,0,1,0,1
cell therapy protocol 2,0,0,0,1,0,1
cellular response,0,0,0,1,0,1
centricyte 1000,0,0,0,1,0,1
centrum adult (under 50) multivitamin,0,0,1,0,0,1
cerc-002,0,0,0,1,0,1
cerebral compliance,0,1,0,0,0,1
cerebral compliance/hemodynamics monitoring,0,1,0,0,0,1
certified cloth face mask,0,0,1,0,0,1
certified cloth face mask/preventive information,0,0,1,0,0,1
chadox1 ncov-19 single dose,0,0,0,1,0,1
chadox1 ncov-19 single dose / paracetamol,0,0,0,1,0,1
chadox1 ncov-19 two dose,0,0,0,1,0,1
chadox1 ncov-19 two dose / paracetamol,0,0,0,1,0,1
change in preference to surgery under covid-19 pandemic.,0,1,0,0,0,1
chat-based instant messaging support,1,0,0,0,0,1
chat-based support,0,0,0,1,0,1
cheek swab,0,0,0,1,0,1
chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
chemotherapy,1,0,0,0,0,1
chest mri,0,0,0,1,0,1
chest x-ray,0,0,0,1,0,1
chiropractic care (more than one visit),0,1,0,0,0,1
chiropractic care (one visit),0,1,0,0,0,1
chlorhexidine,0,0,0,1,0,1
chlorine dioxide,0,0,0,1,0,1
choice of assignment: active choice,0,0,0,1,0,1
choice of assignment: enhanced active choice,0,0,0,1,0,1
choice of assignment: opt-in,0,0,0,1,0,1
chx0.12,0,1,0,0,0,1
chx0.12/cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cig axial,1,0,0,0,0,1
cig tilted,1,0,0,0,0,1
citrox,0,0,0,1,0,1
ck0802,0,0,0,1,0,1
clarithromycin,1,0,0,0,0,1
clarithromycin 500mg,0,1,0,0,0,1
clbs119,0,0,0,1,0,1
clevudine,0,0,0,1,0,1
clinical data collection,0,0,0,1,0,1
clinical diagnosis of covid-19 by a health care professional,0,0,0,1,0,1
clinical features,0,0,0,1,0,1
clinical interview,0,0,0,1,0,1
clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
clinical testing of subjects,0,0,0,1,0,1
"clinical, functional",0,0,0,1,0,1
"clinical, functional/radiological lung involvement evolution",0,0,0,1,0,1
"clinical, laboratory",0,0,0,1,0,1
"clinical, laboratory/imaging characteristics of pneumonia",0,0,0,1,0,1
clinico-biological parameters in routine care,0,0,0,1,0,1
clofazimine,0,0,0,1,0,1
closed-loop control of oxygen supplementation by o2matic,0,1,0,0,0,1
clungene rapid test cassette,0,0,0,1,0,1
cns magnetic resonance imaging (mri) imaging,0,0,0,1,0,1
cod liver oil,0,0,0,1,0,1
cognitive,0,0,0,1,0,1
cognitive behavioral brief-telepsychotherapy,0,0,1,0,0,1
cognitive testing,0,0,0,1,0,1
colchicine pill,0,0,0,1,0,1
colchicine/herbal phenolic monoterpene fractions,0,0,0,1,0,1
colchicine/symptomatic treatment (paracetamol),0,0,0,1,0,1
colgate periogard mouthwash,0,0,1,0,0,1
colgate peroxyl mouthwash,0,0,1,0,0,1
colgate total mouthwash,0,0,1,0,0,1
collagen-polyvinylpyrrolidone,0,0,0,1,0,1
collection of breath sample,0,0,0,1,0,1
collection of mucosal lining fluid,0,1,0,0,0,1
collection of odour samples,0,0,0,1,0,1
collection of swabs,0,0,0,1,0,1
collection of tears,0,0,1,0,0,1
collection of tears/saliva.,0,0,1,0,0,1
colorectal resections,1,0,0,0,0,1
combination,1,0,0,0,0,1
communication type,0,1,0,0,0,1
community-driven messages to promote covid-19 testing,0,0,1,0,0,1
community health worker support,0,0,1,0,0,1
community health workers.,0,0,0,1,0,1
community interest message,0,1,0,0,0,1
comparative observational cohort study,0,0,0,1,0,1
compare the difference in respiratory rate between h0,0,0,0,1,0,1
compassion focused intervention,0,1,0,0,0,1
complement dosage,0,0,0,1,0,1
complete thrombophilic profile testing by multiplex pcr,0,0,0,1,0,1
completion of post telemedicine encounter survey,0,1,0,0,0,1
completion of pre-pandemic survey,0,1,0,0,0,1
completion of survey after peak of pandemic,0,1,0,0,0,1
complex diagnostic panel,0,0,1,0,0,1
comprehensive treatment,0,0,0,1,0,1
conestat alfa,0,0,0,1,0,1
conjunctival swab/nasopharyngeal swab,0,0,0,1,0,1
connected devices measurements,0,0,0,1,0,1
connor-davidson resilience scale 10 items (cd-risc 10),0,0,0,1,0,1
contain covid anxiety ssi,0,1,0,0,0,1
continuation of acei,0,0,0,1,0,1
continuation of acei/arb,0,0,0,1,0,1
continuation of arb,0,0,1,0,0,1
continuation of ras blocker,0,0,0,1,0,1
continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
continuous positive airway pressure,0,0,0,1,0,1
continuous renal replacement therapy,0,0,0,1,0,1
continuous vital sign monitoring - isansys patient status engine,0,0,0,1,0,1
contrast-enhanced cmr,0,0,0,1,0,1
control blend,0,0,0,1,0,1
control message,0,1,0,0,0,1
control patients,0,0,0,1,0,1
control swab,0,0,0,1,0,1
convalescent plasma/standard care,0,0,0,1,0,1
convalscent plasma,0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",0,0,0,1,0,1
conventional oxygen therapy,0,0,0,1,0,1
conventional therapy first,1,0,0,0,0,1
convp,0,0,0,1,0,1
copan swabbing,0,0,0,1,0,1
copan swabbing/blood sample collection,0,0,0,1,0,1
coping strategies video,0,0,0,1,0,1
core warming,0,0,0,1,0,1
corn oil (placebo),0,0,0,1,0,1
coronavac,0,0,0,1,0,1
"coronavirus anxiety scale , covid-19 phobia scale",0,1,0,0,0,1
coronavirus disease 2019,0,0,0,1,0,1
corticosteroids/derivatives,1,0,0,0,0,1
cosh self-help smoking cessation booklet,0,0,0,1,0,1
cospherunate,0,0,1,0,0,1
cospherunate/azythromycine,0,0,1,0,0,1
cospherunate/phytomedicine/azythromycien,0,0,1,0,0,1
counselling,1,0,0,0,0,1
couples' group education,0,0,1,0,0,1
covi-guard,0,0,0,1,0,1
covicu,0,0,0,1,0,1
covid-19 / patients,1,0,0,0,0,1
covid-19 androgen sensitivity test (covast),0,0,1,0,0,1
covid-19 antibody testing,0,0,0,1,0,1
covid-19 antigen,0,0,0,1,0,1
"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",0,0,0,1,0,1
covid-19 barrier box,0,0,0,1,0,1
covid-19 convalescent plasma (cp),0,0,0,1,0,1
covid-19 diagnostic,0,0,0,1,0,1
covid-19 diagnostic test,0,0,0,1,0,1
covid-19 diagnostic/assessment tests,0,0,0,1,0,1
covid-19 experience surveys,0,0,0,1,0,1
covid-19 facility,0,1,0,0,0,1
covid-19 infection,0,0,0,1,0,1
covid-19 infection status,0,0,0,1,0,1
covid-19 infection will be conducted.,0,0,0,1,0,1
"covid-19 pcr , igm",1,0,0,0,0,1
covid-19 positive pregnant women,0,1,0,0,0,1
covid-19 positive via testing,0,0,0,1,0,1
covid-19 presto test,0,0,0,1,0,1
covid-19 related health warning leaflet,0,0,0,1,0,1
covid-19 survey,0,0,0,1,0,1
covid-19 swab,0,0,0,1,0,1
covid-19 test,0,0,0,1,0,1
covid-19 testing,0,0,0,1,0,1
covid-19 treatment,0,0,0,1,0,1
covid-19 treatments,0,1,0,0,0,1
covid-19/ observational,0,0,0,1,0,1
covid-19/intensive care,0,1,0,0,0,1
covid-specific advice,0,0,0,1,0,1
covid-surgres questionaire,0,1,0,0,0,1
covid-viroâ® test,0,0,0,1,0,1
covid 19 diagnostic test,1,0,0,0,0,1
covid 19 impact,0,1,0,0,0,1
covid 19 self-questionnaire,0,0,0,1,0,1
covid 19 serology,0,0,0,1,0,1
covid19 vaccine,0,0,0,1,0,1
covidseq test,0,0,1,0,0,1
covsurf drug delivery system,0,0,0,1,0,1
covx,0,1,0,0,0,1
cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cpi-006,0,0,0,1,0,1
cries 13 questionnaire,0,0,0,1,0,1
crisis intervention therapy,0,0,1,0,0,1
crizanlizumab,0,0,0,1,0,1
cross-sectional observational study,0,1,0,0,0,1
cross-sectional study investigating the association of npis with mental health,0,1,0,0,0,1
cross sectional study using scientifically validated psychometric scales,0,1,0,0,0,1
csvf,0,0,0,1,0,1
ct-p59/placebo,0,0,0,1,0,1
ctus examination,0,0,0,1,0,1
cupping,0,0,0,1,0,1
current care per ucla treating physicians,0,0,0,1,0,1
cvncov 12 î¼g,0,0,0,1,0,1
cvncov 12î¼g,0,0,0,1,0,1
cvncov 6 î¼g,0,0,0,1,0,1
cvncov vaccine,0,0,0,1,0,1
cyp-001,0,0,0,1,0,1
cystatin c,0,0,0,1,0,1
cyt107,0,0,0,1,0,1
cytokines,0,0,0,1,0,1
cytokines measurement,0,0,0,1,0,1
d,0,0,0,1,0,1
d followed by enoxaparin,0,0,0,1,0,1
daily coping toolkit,0,0,0,1,0,1
daily monitoring,0,0,0,1,0,1
daily room disinfection,0,1,0,0,0,1
daily syndromic surveillance,0,0,1,0,0,1
dalargin,1,0,0,0,0,1
danoprevir,0,1,0,0,0,1
danoprevir/ritonavir,0,1,0,0,0,1
dapansutrile capsules,0,0,0,1,0,1
das181,0,1,0,0,0,1
dass-21 instrument (depression,0,0,0,1,0,1
dass-21 instrument (depression/anxiety),0,0,0,1,0,1
data,0,0,0,1,0,1
data collection from blood draw,0,0,0,1,0,1
data collection from lumbar puncture,0,0,0,1,0,1
data collection from medical files,0,0,0,1,0,1
data collection up to 1 year,0,0,0,1,0,1
data collection/clinical testing of subjects,0,0,0,1,0,1
data collection/rhinopharyngeal swab,0,1,0,0,0,1
data collection: clinical care assessments,0,0,1,0,0,1
data monitoring for 48h within the first 12 hours of admission for covid-19,0,0,0,1,0,1
data registry,0,0,0,1,0,1
"data research, database analysis",0,1,0,0,0,1
day,1,0,0,0,0,1
death with routine,1,0,0,0,0,1
decisions of limitations,0,0,0,1,0,1
decisions of limitations/stop processing,0,0,0,1,0,1
decitabine,0,0,0,1,0,1
deep breathing training,0,1,0,0,0,1
deferoxamine,0,0,0,1,0,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
degarelix,0,0,0,1,0,1
deglycyrrhizinated licorice,0,0,0,1,0,1
demographic characteristics,0,1,0,0,0,1
depression scale,0,0,0,1,0,1
"depression,",0,0,0,1,0,1
"depression, anxiety",0,0,0,1,0,1
"depression, anxiety/stress scale",0,0,0,1,0,1
derivatives,1,0,0,0,0,1
derivatives.,0,0,0,1,0,1
description of groups caracteristics,0,1,0,0,0,1
desidustat,0,0,0,1,0,1
device used to record voice for screening,0,0,0,1,0,1
device),0,0,0,1,0,1
dexamethasone 2 mg,0,1,0,0,0,1
dexamethasone 2 mg/ml,0,1,0,0,0,1
dexamethasone/hydroxychloroquine,0,0,0,1,0,1
dexcom,0,0,0,1,0,1
dfv890,0,0,0,1,0,1
diabetes type 2,1,0,0,0,0,1
diagnosed with covid-19,0,0,1,0,0,1
"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",0,0,0,1,0,1
diagnostic,0,0,0,1,0,1
diagnostic examination for venous thromboembolism,0,1,0,0,0,1
diagnostic laboratory biomarker analysis,0,0,0,1,0,1
diagnostic test covid-19,0,0,0,1,0,1
diagnostic test for detection of sars-cov-2,0,0,1,0,0,1
diagnostic test for sars-cov2 for patients,0,0,0,1,0,1
diagnostic test for sars-cov2 for patients/health staff,0,0,0,1,0,1
diagnostic tests for covid-19 infection,0,0,0,1,0,1
dialectical behavioral therapy (dbt) skills,0,0,0,1,0,1
diet tracking,0,0,0,1,0,1
"dietary counselling on food groups according to iyc feeding practices, who",0,0,0,1,0,1
dietary supplement,0,0,0,1,0,1
dietary supplement containing resistant starch,0,0,0,1,0,1
differences in triage,0,1,0,0,0,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,0,1,0,0,0,1
dig axial,1,0,0,0,0,1
dig tilted,1,0,0,0,0,1
digital cardiac counseling,0,0,0,1,0,1
digital health online platform,0,0,0,1,0,1
digital oximeter monitoring,0,0,0,1,0,1
diovan,0,0,0,1,0,1
dipyridamole er 200mg,0,0,0,1,0,1
dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,0,0,0,1,0,1
direct antigen tests for covid-19,0,1,0,0,0,1
discontinuation of acei,0,0,0,1,0,1
discontinuation of acei/arb,0,0,0,1,0,1
discontinuation of arb,0,0,1,0,0,1
discontinuation of ras blocker,0,0,0,1,0,1
discussion board for social support,1,0,0,0,0,1
discussion board for social support /basic feedback,1,0,0,0,0,1
discussion board for social support/personalized feedback,1,0,0,0,0,1
distance learning,0,0,1,0,0,1
dlco,0,0,0,1,0,1
dociparastat sodium,0,0,0,1,0,1
doctor spot,0,0,0,1,0,1
doppler echo,0,0,0,1,0,1
dose finding phase (mtd),0,0,0,1,0,1
double-blind nt-i7,0,0,0,1,0,1
doxycyline,0,1,0,0,0,1
drugs,0,0,0,1,0,1
drugs/supportive care,0,0,0,1,0,1
duplex sonography,0,0,0,1,0,1
duplex ultrasound/computed tomography angiography,0,1,0,0,0,1
dur-928,0,0,0,1,0,1
during covid-19 pandemic,0,0,0,1,0,1
during hospitalization blood samples,0,0,0,1,0,1
dutasteride,0,0,0,1,0,1
duvelisib,0,0,0,1,0,1
dysphagia handicap index (dhi),0,0,0,1,0,1
ðžxygen therapy,0,0,0,1,0,1
early-dexamethasone,0,0,0,1,0,1
early rehabilitation,0,0,0,1,0,1
earsats pulse oximeter probe,0,0,0,1,0,1
easycov poc,0,0,0,1,0,1
eating habits,0,0,0,1,0,1
ec-18,0,0,0,1,0,1
ecco2r,0,0,0,1,0,1
ecg-holter,0,0,0,1,0,1
echo-doppler,0,0,0,1,0,1
echocardiogram,0,0,0,1,0,1
economic benefit message,0,1,0,0,0,1
economic freedom message,0,1,0,0,0,1
eculizumab,0,0,0,1,0,1
education sessions,0,0,0,1,0,1
educational meetings/visual prompts,0,1,0,0,0,1
educational video,1,0,0,0,0,1
eeg,0,1,0,0,0,1
eit-group,0,0,0,1,0,1
ejaculated semen sample,0,0,0,1,0,1
elective cancer surgery,0,0,0,1,0,1
electric pad for human external pain therapy,0,0,0,1,0,1
electrical impedance tomography,0,0,0,1,0,1
electrocardiogram (ecg),0,0,0,1,0,1
"electrocardiogram, telemetry, echocardiogram, laboratory values",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",0,0,0,1,0,1
electrolytes,1,0,0,0,0,1
electronic health record review,0,0,0,1,0,1
elisa/rapid test to detect antibodies against covid-19,1,0,0,0,0,1
elmo project at covid-19: proof of concept,0,0,0,1,0,1
elmo project at covid-19: proof of concept/usability,0,0,0,1,0,1
elmo project at covid-19: study in humans,0,0,0,1,0,1
eltrombopag,0,0,0,1,0,1
emapalumab,0,0,0,1,0,1
embarrassment message,0,1,0,0,0,1
emdr,0,0,0,1,0,1
emergency laparotomy,0,1,0,0,0,1
emergency surgery,0,1,0,0,0,1
emotion regulation training via telehealth,0,0,0,1,0,1
emotional freedom technique,0,1,0,0,0,1
emotional support plan,0,0,0,1,0,1
emtricitabine/tenofovir,0,0,0,1,0,1
emtricitabine/tenofovir disoproxil,0,0,0,1,0,1
endoscopic intervention,0,1,0,0,0,1
endoscopic management according to standard of care,0,1,0,0,0,1
endoscopic procedure,0,1,0,0,0,1
endoscopy,0,1,0,0,0,1
endothelial damage,0,0,0,1,0,1
endothelial damage/angiogenic biomarkers,0,0,0,1,0,1
enduring happiness,0,0,1,0,0,1
enduring happiness/continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
enhanced hygiene measures,1,0,0,0,0,1
enoxaparin/lovenox,0,0,0,1,0,1
enriched survey feedback,1,0,0,0,0,1
ensifentrine,0,0,0,1,0,1
ent exam,0,0,0,1,0,1
enterally,0,0,0,1,0,1
entrã©e: behavioral skills,0,0,0,1,0,1
entrã©e: cognitive skills,0,0,0,1,0,1
entrã©e: interpersonal skills,0,0,0,1,0,1
environmental exposure,0,0,0,1,0,1
environmental exposure/clinical features,0,0,0,1,0,1
enzalutamide,0,0,0,1,0,1
ep,0,1,0,0,0,1
epds (edinburgh postnatal depression scale),0,1,0,0,0,1
epic risk score display,0,0,0,1,0,1
epidemiological,0,1,0,0,0,1
epidemiological/demographic characteristics,0,1,0,0,0,1
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),1,0,0,0,0,1
equipment with smartwatch throughout hospital stay on the general ward,0,0,0,1,0,1
escin,0,0,0,1,0,1
essential oil blend,0,0,0,1,0,1
essential oils,0,1,0,0,0,1
estradiol,0,0,0,1,0,1
etoposide,0,0,0,1,0,1
euroimmun assay,0,0,0,1,0,1
evaluate hacor score effectivity in this patients,0,0,0,1,0,1
evaluation,0,0,0,1,0,1
evaluation of changes in the diagnostic-therapeutic pathway,0,1,0,0,0,1
"evaluation of clinical, instrumental",0,0,0,1,0,1
"evaluation of clinical, instrumental/laboratory diagnostics tests",0,0,0,1,0,1
evaluation of skin microvascular flow,0,0,0,1,0,1
evaluation of skin microvascular flow/reactivity,0,0,0,1,0,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),0,0,0,1,0,1
evaluation of the ferritin,0,0,0,1,0,1
even birth year intervention groups,0,0,0,1,0,1
examinations for the research:,0,0,0,1,0,1
examine the impact of covid-19 during pregnancy,0,0,0,1,0,1
exercise booklet,0,0,0,1,0,1
exercise program,0,0,0,1,0,1
exercise test ecg,0,0,0,1,0,1
exercise training,0,0,0,1,0,1
exhaled breath sampling,0,0,0,1,0,1
experiences of health care professionals working in intensive care units during the covid-19 pandemic,0,0,0,1,0,1
experimental group,0,0,0,1,0,1
experimental: questionnaire without precaution information,0,1,0,0,0,1
experts consensus,0,1,0,0,0,1
exposure surveys,1,0,0,0,0,1
exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
exposure to the dutch measures due to the covid-19 pandemic.,0,0,0,1,0,1
extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,0,0,0,1,0,1
extracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
extracorporeal membrane oxygenation,0,0,0,1,0,1
eye movement desensitisation,0,0,0,1,0,1
eye movement desensitisation/reprocessing recent traumatic event protocol,0,0,0,1,0,1
f-652,0,0,0,1,0,1
face mask,0,0,0,1,0,1
face mask awareness,0,0,0,1,0,1
face mask sampling,0,0,0,1,0,1
facial fractures reduction,0,1,0,0,0,1
facial fractures reduction/osteosynthesis,0,1,0,0,0,1
facial mask,0,0,0,1,0,1
family nurture intervention (fni),0,0,0,1,0,1
familychildcare (provisional name of app),0,0,1,0,0,1
farmalarm,0,1,0,0,0,1
favipiravir / standard care,1,0,0,0,0,1
favipiravir/azithromycin,0,0,0,1,0,1
favipiravir/chloroquine,0,0,0,1,0,1
favipiravir/nitazoxanide,0,0,0,1,0,1
favipiravir/tocilizumab,0,0,0,1,0,1
favorable outcome,0,1,0,0,0,1
fecal,0,0,0,1,0,1
fecal sample,0,0,0,1,0,1
fenofibrate,0,0,1,0,0,1
ffp,0,0,0,1,0,1
ffp2,0,0,0,1,0,1
fibreoptic endoscopic evaluation of swallowing (fees),0,0,0,1,0,1
fibrin generation markers assays,0,0,0,1,0,1
filmarray pneumonia,0,1,0,0,0,1
filtration test,0,1,0,0,0,1
fingerstick,0,0,0,1,0,1
fingertip tests for poc assays,0,0,0,1,0,1
fisetin,0,0,1,0,0,1
fit test,0,1,0,0,0,1
fitted pva strip,0,0,0,1,0,1
flow controlled ventilation (evone-ventilator),0,0,0,1,0,1
flu shot,0,0,1,0,0,1
fluoxetine,0,0,0,1,0,1
fluvoxamine,1,0,0,0,0,1
fmd,0,0,0,1,0,1
fmf.,0,0,1,0,0,1
folic acid,1,0,0,0,0,1
follow-up of patients with covid-19,0,0,0,1,0,1
follow-up phone call,0,1,0,0,0,1
follow up,1,0,0,0,0,1
follow up calls,0,0,0,1,0,1
fondapariniux,0,0,0,1,0,1
formoterol,0,0,0,1,0,1
freestyle libre 14 day cgm system,0,0,0,1,0,1
fsfi survey,0,1,0,0,0,1
functional mri,0,0,0,1,0,1
further processing of health data,0,0,0,1,0,1
gad-7 (7-item generalized anxiety disorder),0,0,0,1,0,1
gad-7 (general anxiety disorder) scale,0,1,0,0,0,1
gad-7 general anxiety disorder scale,0,0,0,1,0,1
gam-covid-vac lyo,0,1,0,0,0,1
gamification,0,0,0,0,1,1
gammacoreâ® (vagus nerve stimulation),0,0,0,1,0,1
gammacoreâ® sapphire (non-invasive vagus nerve stimulator),0,0,0,1,0,1
gamunex-c,0,0,0,1,0,1
ganovo,0,1,0,0,0,1
ganovo/ritonavir//-interferon nebulization,0,1,0,0,0,1
"garadacimab, factor xiia antagonist monoclonal antibody",0,0,0,1,0,1
gargle,0,0,0,1,0,1
gas exchange measurement,0,1,0,0,0,1
gas exchanges at different peep,0,1,0,0,0,1
gastrointestinal endoscopy,0,1,0,0,0,1
gc4419,0,0,0,1,0,1
gc5131,0,0,0,1,0,1
general anesthesia,0,0,0,1,0,1
general health education,0,0,0,1,0,1
general public cohort,0,0,0,1,0,1
generalized anxiety disorder-7 (gad-7),0,1,0,0,0,1
genetic,0,0,0,1,0,1
gimsilumab,1,0,0,0,0,1
global longitudinal strain,0,0,0,1,0,1
global survey,0,0,1,0,0,1
gloves,0,1,0,0,0,1
gls-1200,0,0,0,1,0,1
glycaemic levels,0,0,0,1,0,1
glycine,0,0,0,1,0,1
glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
gns561,0,0,0,1,0,1
go2 peep mouthpiece,0,1,0,0,0,1
"gps reports of potential patient safety incidents, non-covid-19 related",0,1,0,0,0,1
grad-cov2,0,0,0,1,0,1
grandiosity subscales,0,0,0,1,0,1
group 1,1,0,0,0,0,1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,0,0,0,1,0,1
group1,0,0,0,1,0,1
growth mindset ssi,0,0,0,1,0,1
guided online support program,0,0,0,1,0,1
guilt message,0,1,0,0,0,1
gustatory tests,0,0,0,1,0,1
gx-19,0,0,0,1,0,1
h12 of the initiation of morphine between the control,0,0,0,1,0,1
had5-s-fusion,0,0,0,1,0,1
had5-s-fusion/n-etsd vaccine,0,0,0,1,0,1
hads,0,0,0,1,0,1
health-related quality of life,0,0,0,1,0,1
health care worker survey,0,0,0,1,0,1
health enhancement program,0,0,0,1,0,1
health literacy,0,0,0,1,0,1
health staff,0,0,0,1,0,1
health supplements,0,0,0,1,0,1
health warning leaflet,0,0,0,1,0,1
healthy lifestyle advise,0,0,0,1,0,1
healthy minds program foundations training,0,0,0,1,0,1
hemodynamics changes at different peep,0,1,0,0,0,1
hemodynamics monitoring,0,1,0,0,0,1
hepatitis a vaccine,0,0,0,1,0,1
herbal phenolic monoterpene,0,0,0,1,0,1
hfb30132a,0,0,0,1,0,1
high-dose placebo (18-59 years),0,0,0,1,0,1
high-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years),0,0,0,1,0,1
high-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
high dose radiation 100 cgy,0,0,0,1,0,1
high flow nasal cannula (hfnc),0,0,0,1,0,1
high intensity interval training,1,0,0,0,0,1
high peep with end inspiratory pause,0,0,0,1,0,1
high peep without end inspiratory pause,0,0,0,1,0,1
holter monitor,0,1,0,0,0,1
home-cov rule implementation,0,1,0,0,0,1
home-use test,0,0,0,1,0,1
home care monitoring,0,0,0,0,1,1
home exercise,0,0,0,1,0,1
home pulse oximetry monitoring,0,1,0,0,0,1
home sample collection of concerning mole with physician supervision,1,0,0,0,0,1
home sleep apnea testing,1,0,0,0,0,1
home sleep apnea testing/in-hospital polysomnography,1,0,0,0,0,1
home spirometry,0,0,0,1,0,1
hope intervention,1,0,0,0,0,1
hospital acquired infection,0,0,0,1,0,1
hospital admission,0,0,0,1,0,1
hospital anxiety,0,0,0,1,0,1
hospital anxiety/depression scale,0,0,0,1,0,1
"hospitalisation, necessity of icu, mortality rate, lung involvement",0,0,0,1,0,1
hospitalized children with covid19,0,0,0,1,0,1
hospitalized patients for covid-19 infection,0,0,0,1,0,1
human milk donors,0,0,0,1,0,1
human recombinant interleukin 2,0,0,0,1,0,1
hydrocortisone,1,0,0,0,0,1
hydrogen oxygen generator with nebulizer,0,1,0,0,0,1
hydroxychloroquine / metabolic cofactor supplementation,0,0,0,1,0,1
hydroxychloroquine / oxygen,0,1,0,0,0,1
hydroxychloroquine / sorbitol,0,0,0,1,0,1
hydroxychloroquine/azithromycin/ tocilizumab,1,0,0,0,0,1
hydroxychloroquine/clindamycin,0,1,0,0,0,1
hydroxychloroquine/clindamycin/primaquine,0,1,0,0,0,1
hydroxychloroquine/doxycycline,0,1,0,0,0,1
hydroxychloroquine/lopinavir/ritonavir,0,0,0,1,0,1
hydroxychloroquine/placebo,0,0,0,0,1,1
hydroxyvitamin,0,0,0,1,0,1
hyperimmune immunoglobulin to sars-cov-2 (hivig),0,0,0,1,0,1
hypertension,1,0,0,0,0,1
hypothermia via cooling machine- arctic sun 5000,0,0,0,1,0,1
icatibant,0,0,0,1,0,1
icosapent ethyl,0,0,0,1,0,1
icosapent ethyl (ipe),0,0,0,1,0,1
icu recovery,0,0,0,1,0,1
icu recovery / physical therapy,0,0,0,1,0,1
id now vs. accula,0,0,0,1,0,1
ier-r (posttraumatic stress),0,0,0,1,0,1
ifx-1,0,0,0,1,0,1
igg antibodies assay,0,0,0,1,0,1
igg sars cov 2 antibodies,1,0,0,0,0,1
igg sars cov2,1,0,0,0,0,1
"igg, aaz, boulogne-billancourt, france)",0,0,0,1,0,1
igiv,0,0,0,1,0,1
igm test,0,0,1,0,0,1
igm/igg antibodies assay,0,0,0,1,0,1
iibr-100 high-dose (prime),0,0,0,1,0,1
iibr-100 low-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium dose (prime),0,0,0,1,0,1
"iibr-100, low dose (prime)",0,0,0,1,0,1
imaging,0,0,0,1,0,1
imaging by thoracic scanner,1,0,0,0,0,1
imaging characteristics of pneumonia,0,0,0,1,0,1
"imaging, blood tests",0,1,0,0,0,1
imm-101,0,0,0,1,0,1
immediate vs. delayed provision of antibody test results,1,0,0,0,0,1
immune globulin,0,0,0,1,0,1
immune plasma,0,0,0,1,0,1
immunfluorescence,0,0,0,1,0,1
immunofree tablets,0,0,0,1,0,1
immunofree tablets/reginmune capsule,0,0,0,1,0,1
immunoglubulins,0,0,0,1,0,1
immunological,0,0,0,1,0,1
immunosuppressive,0,0,0,1,0,1
immunosuppressive agents,0,0,0,1,0,1
impact event score,0,0,0,1,0,1
impact of event scale-revised,0,0,0,1,0,1
impulseâ„¢ una e-stethoscope,0,0,0,1,0,1
in-hospital mortality rate,0,1,0,0,0,1
inactivated sars cov 2 vaccine (vero cell). wuhan,0,0,0,1,0,1
inactivated vaccine,0,0,0,1,0,1
inb03,0,0,0,1,0,1
indian costus,0,0,0,1,0,1
indirect calorimetry,0,0,0,1,0,1
individualized-chinese herbal medicine,0,0,0,1,0,1
indomethacin,0,0,0,1,0,1
infectious disease,0,0,0,1,0,1
infectious disease/cardiology clinical consultations,0,0,0,1,0,1
inflammatory cytokines,0,0,0,1,0,1
inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
informational videos,0,0,0,1,0,1
informational videos/social media campaigns encouraging cancer screening.,0,0,0,1,0,1
informed consent,0,0,0,1,0,1
injection,0,0,0,1,0,1
inm005,1,0,0,0,0,1
innova lateral flow device,0,0,0,1,0,1
inopulse,0,0,0,1,0,1
instrumental activities of daily living shaping,0,0,0,1,0,1
insulin,0,0,0,1,0,1
integrated clinical evaluation,0,0,0,1,0,1
intensive care,0,1,0,0,0,1
intensive care unit admission ratio,0,0,0,1,0,1
interferon-ãÿ-1a,0,0,0,1,0,1
interferon-î² 1a,0,0,1,0,0,1
interleuken 6,0,0,0,1,0,1
intermediate dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
intermittent,1,0,0,0,0,1
internet-based cognitive behavioral therapy,0,0,1,0,0,1
internet-based guided self-help based on cbt principles,0,0,0,1,0,1
internet-based self-help,0,0,0,1,0,1
internet-based self-help after 3 weeks,0,0,0,1,0,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,0,0,0,0,1
intervention app,0,1,0,0,0,1
intervention group coronacope,0,0,0,1,0,1
intervention group_rehabilitation program,0,0,0,1,0,1
intervention program,0,0,0,1,0,1
interventional groups,0,0,0,1,0,1
interview by psychologists,0,0,0,1,0,1
intracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
intramuscular vaccine,1,0,0,0,0,1
intraosseous,0,1,0,0,0,1
intravenous,0,1,0,0,0,1
intravenous drug,0,0,0,1,0,1
invasive mechanical ventilation,0,1,0,0,0,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,0,1,0,0,0,1
investigation of smell,0,0,0,1,0,1
investigation of smell/taste disorders,0,0,0,1,0,1
investigation of the prevalence of test positivity,0,0,0,1,0,1
investigational product - viracide,0,0,0,1,0,1
ion mobility spectrometry (ims),0,0,0,1,0,1
iota-carrageenan,0,0,0,1,0,1
iota carrageenan nasal spray,0,1,0,0,0,1
iota carrageenan nasal spray/ivermectin oral drops (used as buccal drops),0,1,0,0,0,1
ip-10,0,1,0,0,0,1
isis 721744,0,0,0,1,0,1
isoflurane inhalant product,0,0,0,1,0,1
isoquercetin,0,0,0,1,0,1
itolizumab,0,1,0,0,0,1
its,0,0,0,1,0,1
iv tocillizumab (tcz),0,0,0,1,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg,0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,0,1,0,0,0,1
ivermectin / chloroquine,0,0,0,1,0,1
ivermectin / doxycycline,0,1,0,0,0,1
ivermectin / doxycycline / placebo,0,0,1,0,0,1
ivermectin / placebo,0,0,1,0,0,1
"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
ivermectin/deamethisone/aspirin,0,1,0,0,0,1
ivermectin/deamethisone/exoparin,0,1,0,0,0,1
ivermectin/doxycycline,0,1,0,0,0,1
ivermectin/doxycyline,0,1,0,0,0,1
ivig,0,1,0,0,0,1
kaletra,0,0,0,1,0,1
kaletra/beta interferon,0,0,0,1,0,1
kamada anti-sars-cov-2,0,0,0,1,0,1
kelea water,0,0,0,1,0,1
ketamine,0,0,0,1,0,1
ketogenic diet,0,0,0,1,0,1
ketogenic diet with phytoextracts,0,0,0,1,0,1
ketotifen,0,1,0,0,0,1
kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
kg once daily,0,1,0,0,0,1
kir phenotype evaluation,0,0,0,1,0,1
"knowledge, attitude, practice, awareness, preference",0,1,0,0,0,1
kundalini yoga,0,0,0,1,0,1
kundalini yoga/anxiety reduction training,0,0,0,1,0,1
lab workup (on admission,0,0,0,1,0,1
lab workup (on admission/regularly during follow up).,0,0,0,1,0,1
laboratory,0,0,0,1,0,1
laboratory analyses,0,0,0,1,0,1
laboratory diagnostics tests,0,0,0,1,0,1
laboratory test positive for sars-cov-2 virus,0,0,1,0,0,1
labs,0,0,0,1,0,1
lactobaciltus rhamnosus gg,0,0,0,1,0,1
lambda 180 mcg s.c,0,0,0,1,0,1
lamp,0,0,0,1,0,1
lanadelumab,0,0,0,1,0,1
laparoscopic,0,1,0,0,0,1
laparoscopic/open appendicectomy,0,1,0,0,0,1
laryngoscope,1,0,0,0,0,1
laryngoscopy,0,0,0,1,0,1
lateral position (left,0,0,0,1,0,1
lateral position (left/right lateral decubitus),0,0,0,1,0,1
lau-7b,0,0,0,1,0,1
lay telephone coaching,0,0,1,0,0,1
leaf-4l6715,0,0,0,1,0,1
leflunomide,0,0,0,1,0,1
let it out (lio)-c,0,0,0,0,1,1
leukapheresis,0,0,0,1,0,1
levamisole,0,0,0,1,0,1
levamisole / budesonide/formoterol,0,0,0,1,0,1
levilimab,0,1,0,0,0,1
liberase enzyme,0,0,0,1,0,1
licensed seasonal influenza vaccine,0,0,0,1,0,1
licorice extract,0,0,0,1,0,1
life2000â® ventilator,0,0,0,1,0,1
lifesignals biosensor 1ax*,0,0,0,1,0,1
lifestyle change promotion program,0,0,0,1,0,1
lifestyle habits,0,1,0,0,0,1
limbix spark,0,0,0,1,0,1
linagliptin,0,0,0,1,0,1
linagliptin 5 mg,0,0,0,1,0,1
liposomal,0,1,0,0,0,1
liquid alpha1-proteinase inhibitor (human),0,0,0,1,0,1
liver,0,0,1,0,0,1
lmwh,0,1,0,0,0,1
lock-down,0,1,0,0,0,1
lock-down/social distancing,0,1,0,0,0,1
longeveron mesenchymal stem cells (lmscs),0,0,0,1,0,1
longitudinally,0,0,0,1,0,1
lopinavir 200 mg,1,0,0,0,0,1
lopinavir 200 mg / ritonavir 50 mg [kaletra],1,0,0,0,0,1
lopinavir/ ritonavir,0,0,0,1,0,1
lopinavir/ritonavir / hydoxychloroquine,0,0,0,1,0,1
losartan 50 mg,0,0,0,1,0,1
losartan 50 mg/spironolactone 25 mg pillules oral use,0,0,0,1,0,1
losmapimod,0,0,0,1,0,1
lovenox,0,0,0,1,0,1
low-dose placebo (18-59 years),0,0,0,1,0,1
low-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years),0,0,0,1,0,1
low-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
low-molecular-weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin/placebo,0,0,0,1,0,1
low peep - fio2 high,0,0,0,1,0,1
low peep - fio2 low,0,0,0,1,0,1
low/upper respiratory tract sample,0,0,0,1,0,1
lsalt peptide,0,0,0,1,0,1
lung ct scan analysis in covid-19 patients,0,0,0,1,0,1
lung function test,0,0,1,0,0,1
lung function tests,0,0,0,1,0,1
lung impedance,0,0,0,1,0,1
lung mechanics at different peep,0,1,0,0,0,1
lung ultrasound (lus),0,0,0,1,0,1
lung ultrasound use in patients hospitalized with covid,0,0,0,1,0,1
lv-smenp-dc vaccine,0,0,0,1,0,1
lv-smenp-dc vaccine/antigen-specific ctls,0,0,0,1,0,1
ly3127804,0,0,0,0,1,1
m-m-r ii â® vaccine,0,0,0,1,0,1
m5049,0,0,0,1,0,1
machine learning,0,0,0,1,0,1
machine learning model,0,1,0,0,0,1
machine learning/ai algorithm,0,0,0,1,0,1
magec spine rod,0,0,0,1,0,1
magnetic resonance imaging,0,0,0,1,0,1
magnetic resonance spectroscopy (mrs).,0,0,0,1,0,1
maintenance,0,0,0,1,0,1
makair,0,0,0,1,0,1
management of covid-19,0,0,0,1,0,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,0,1,0,0,0,1
manremyc,0,0,0,1,0,1
marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),0,0,0,1,0,1
mas825,0,0,0,1,0,1
"masimo, lidco",0,0,0,1,0,1
masitinib,0,0,0,1,0,1
masked saline placebo,0,0,0,1,0,1
maslach burnout inventory (mbi),0,1,0,0,0,1
masseter inhibitory reflex,0,0,0,1,0,1
massive parallel sequencing of host genome,0,0,0,1,0,1
"maternal attachment, edinburgh depression scoring",1,0,0,0,0,1
"maternal attachment, edinburgh depression scoring/postpartum anxiety scale scores",1,0,0,0,0,1
maternal stress,0,0,0,1,0,1
matrix m1-adjuvant,0,0,0,1,0,1
maximal effort test,0,0,0,1,0,1
mcc ims,0,1,0,0,0,1
mcgrath videolaryngoscope,1,0,0,0,0,1
measles-mumps-rubella vaccine,0,0,0,1,0,1
measurement of circulating sflt1 concentration,0,0,0,1,0,1
mechanical trombectomy,0,1,0,0,0,1
media intervention,0,0,0,1,0,1
medical mask,0,0,0,1,0,1
medical record review - inpatient treatment,0,0,0,1,0,1
medication review,0,0,0,1,0,1
meditation app usage,0,0,0,1,0,1
meditation therapy,0,0,0,1,0,1
meditation/anxiety reduction training,0,0,0,1,0,1
medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,0,0,0,1,0,1
mefloquine/azithromycin/ tocilizumab,1,0,0,0,0,1
melatonin intravenous,0,0,0,1,0,1
melphalan,0,0,0,1,0,1
menacwy prime,0,0,0,1,0,1
menacwy prime/saline placebo boost / paracetamol,0,0,0,1,0,1
menacwy single dose,0,0,0,1,0,1
menacwy single dose / paracetamol,0,0,0,1,0,1
menacwy vaccine,0,0,0,1,0,1
mencare,0,0,1,0,0,1
mencare//bandebereho fathers'/couples' group education,0,0,1,0,0,1
mental imagery,0,0,0,1,0,1
mental well-being,0,1,0,0,0,1
meplazumab,0,0,0,1,0,1
merimepodib,1,0,0,0,0,1
mesenchymal stromal cell-based therapy,0,0,0,1,0,1
mesenchymalÂ stem cells/heparin,0,1,0,0,0,1
messaging,0,1,0,0,0,1
metabolic cofactor supplementation,0,0,0,1,0,1
metabolomic,0,0,0,1,0,1
metanebâ® system,0,0,0,1,0,1
metenkefalin,1,0,0,0,0,1
metenkefalin / tridecactide,1,0,0,0,0,1
metformin glycinate,0,0,0,1,0,1
methotrexate-lde phase 1,0,0,0,1,0,1
methotrexate-lde phase 2,0,0,0,1,0,1
methylene-blue photodisinfection,0,0,0,1,0,1
methylene blue,0,0,0,1,0,1
methylene blue/ vitamin c/n-acetyl cysteine,0,0,0,1,0,1
methylprednisolone injectable product,0,0,0,1,0,1
methylprednisolone injection,0,1,0,0,0,1
mf59 adjuvanted sars-cov-2 sclamp vaccine,0,0,0,1,0,1
mfs,0,0,0,1,0,1
mhealth assessments,0,0,0,1,0,1
microcirculation recording,0,0,0,1,0,1
micronized,0,0,0,1,0,1
"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",0,0,0,1,0,1
microscopy of defined brain regions on autopsy specimens,0,0,0,1,0,1
mindfullness training,0,1,0,0,0,1
mindfulness-based cognitive therapy,0,0,0,1,0,1
mindfulness session(s),0,0,0,1,0,1
mindfulness training,0,0,0,1,0,1
minimal attention control intervention,0,0,0,1,0,1
miniprobe alveoflex,0,0,0,1,0,1
ml intravenous solution [actemra]_#1,0,0,0,1,0,1
ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
"ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",0,1,0,0,0,1
ml prefilled syringe [kineret],0,0,0,1,0,1
mls laser,0,1,0,0,0,1
mmrc (modified medical research council) dyspnea scale,0,0,0,1,0,1
mobile internet survey on self-test,0,1,0,0,0,1
model building,0,1,0,0,0,1
model validation,0,1,0,0,0,1
moderate intensity aerobic exercises,0,1,0,0,0,1
modification,0,0,0,1,0,1
modified rankin score,0,1,0,0,0,1
molgramostim nebuliser solution,0,0,0,1,0,1
mometasone furoate nasal spray,0,1,0,0,0,1
monitoring for aggravation,0,0,0,1,0,1
monitoring visit,0,0,0,1,0,1
monoclonal antibody,0,0,0,1,0,1
montmorrillonite,0,1,0,0,0,1
mortality,0,0,0,1,0,1
mouthrinse with bãªta-cyclodextrin,0,0,0,1,0,1
mouthrinse with bãªta-cyclodextrin/citrox,0,0,0,1,0,1
mouthrinse without bãªta-cyclodextrin,0,0,0,1,0,1
mouthrinse without bãªta-cyclodextrin/citrox,0,0,0,1,0,1
moxibustion,0,0,0,1,0,1
moxibustion/cupping,0,0,0,1,0,1
mr,0,0,0,1,0,1
mr-pro-adm,0,0,0,1,0,1
mr/m-m-r ii â® vaccine,0,0,0,1,0,1
"mri (heart, brain, lungs, liver)",0,0,0,1,0,1
mri scans,0,0,0,1,0,1
mrna in urine test,1,0,0,0,0,1
mrx-4dp0004,0,0,0,1,0,1
msc,0,0,0,1,0,1
mstt1041a,0,0,0,1,0,1
mucodentol,0,0,0,1,0,1
multicapillary column coupled ion mobility spectrometry,0,0,0,1,0,1
multifrequency bioimpedance spectroscopy,0,0,0,1,0,1
multistem,0,0,0,1,0,1
muscle relaxation therapy,0,0,0,1,0,1
musclesound ultrasound,0,0,0,1,0,1
mvc-cov1901,0,0,0,1,0,1
n-acetyl cysteine,1,0,0,0,0,1
n-etsd vaccine,0,0,0,1,0,1
n95 respirator,0,0,0,1,0,1
na-831/atazanavir,0,0,0,1,0,1
na-831/dexamethasone,0,0,0,1,0,1
na (no intervention),0,0,0,1,0,1
nä°cas,0,0,0,1,0,1
naltrexone,0,0,0,1,0,1
nasal high flow,0,1,0,0,0,1
nasal lavage,0,0,1,0,0,1
nasopharyngeal,0,1,0,0,0,1
nasopharyngeal (np) swab,1,0,0,0,0,1
nasopharyngeal/throat swab,0,1,0,0,0,1
nasovax,0,0,0,1,0,1
ncapp,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa),0,0,0,1,0,1
nebulised unfractionated heparin (ufh),0,0,0,1,0,1
netosis markers,0,0,0,1,0,1
neural network diagnosis algorithm,0,0,0,1,0,1
neurocognitive assessment,0,0,0,1,0,1
neuromuscular,0,0,0,1,0,1
neuromuscular electrical stimulation,0,0,0,1,0,1
neutral writing control,0,0,0,0,1,1
newborns,0,1,0,0,0,1
next generation sequencing (ngs) analysis,0,0,0,1,0,1
ng biotech,0,0,0,1,0,1
ng test,0,0,0,1,0,1
ngm621,0,0,0,1,0,1
nhanes smell,0,0,0,1,0,1
nhanes smell/taste tests,0,0,0,1,0,1
niclosamide suspension,0,0,0,1,0,1
nicotinamide riboside,0,0,0,1,0,1
nicotine patch,0,0,0,1,0,1
nigella sativa oil,0,0,0,1,0,1
nintedanib,0,0,0,1,0,1
nintedanib 150 mg [ofev],0,0,0,1,0,1
nioâ® (intraosseous access),1,0,0,0,0,1
nitazoxanide / ivermectin,0,0,0,1,0,1
nitazoxanide/atazanavir/ritonavir,0,0,0,1,0,1
nitric oxide delivered via lungfitâ„¢ system,0,0,0,1,0,1
nk-1r antagonist,0,0,0,1,0,1
no-immunosuppressive,0,0,0,1,0,1
no instruction regarding positioning,0,0,0,1,0,1
no intervention (survey study for medical doctors).,0,0,0,1,0,1
no intervention planned due to the observational study design only a diagnostic testing,0,0,1,0,0,1
no interventional study,1,0,0,0,0,1
no racial inequality highlighting,1,0,0,0,0,1
no research related technology based social interactions,0,0,1,0,0,1
no special intervention,0,1,0,0,0,1
non,0,0,1,0,0,1
non-acei,1,0,0,0,0,1
non-acei/arb,1,0,0,0,0,1
non-contact mce system,0,1,0,0,0,1
non-hospitalization procedures,0,0,0,1,0,1
non-interventional study,0,0,0,1,0,1
non-invasive red lllt treatment to chest of patient.,0,0,0,1,0,1
non-invasive ventilatory support,1,0,0,0,0,1
non-mindfulness intervention,0,0,0,1,0,1
non intervention,0,0,0,1,0,1
non interventional study,0,0,0,1,0,1
non invasive visual acuity testing,1,0,0,0,0,1
none - na,0,1,0,0,0,1
none - observational,0,0,0,1,0,1
"none, this study is observational",0,0,0,1,0,1
noninvasive ventilation,0,1,0,0,0,1
normal saline intranasal,0,0,0,1,0,1
"nose swabs, bronchoalveolar lavage ,urine)",0,0,0,1,0,1
nosocomial,0,0,0,1,0,1
not applicable (observational study),0,0,0,1,0,1
not bravery message,0,1,0,0,0,1
nox66,0,0,0,1,0,1
np-120 (ifenprodil),0,0,0,1,0,1
nps test,0,0,0,1,0,1
nudge,0,0,0,0,1,1
nusepinâ® 0.1 mg,0,0,0,1,0,1
nusepinâ® 0.2 mg,0,0,0,1,0,1
nutrition consult,0,0,0,1,0,1
nutrition consult/protein supplementation,0,0,0,1,0,1
nutritional assessment,0,0,0,1,0,1
nutritional intervention,0,0,0,1,0,1
nuvastatic,0,0,0,1,0,1
obesity,1,0,0,0,0,1
observation for study group,1,0,0,0,0,1
observation of covid 19 pneumonia,0,0,0,1,0,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,1,0,0,0,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",0,0,0,1,0,1
obvio-19 app,0,0,0,1,0,1
occupational health workers,0,0,0,1,0,1
octaplas,0,0,0,1,0,1
odd,0,0,0,1,0,1
odd/even birth year intervention groups,0,0,0,1,0,1
olfaction testing,0,0,0,1,0,1
olfactometry,0,0,0,1,0,1
olfactory,0,0,0,1,0,1
olfactory device,0,0,0,1,0,1
olfactory function evaluation,0,0,0,1,0,1
olfactory/gustatory tests,0,0,0,1,0,1
olokizumab,0,1,0,0,0,1
omega 3/nigella sativa oil,0,0,0,1,0,1
omega 3/nigella sativa oil/anise seed capsule,0,0,0,1,0,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,0,0,0,1,0,1
omega 3/nigella sativa oil/indian costus,0,0,0,1,0,1
omega 3/nigella sativa oil/quinine pills,0,0,0,1,0,1
omeprazole,0,0,0,1,0,1
omnibiotic aad,0,0,0,1,0,1
one covid-19 vaccine candidate (tmv-083) administration - high dose,0,0,0,1,0,1
online intervention mental health covid-19,0,0,0,1,0,1
op-101,0,0,0,1,0,1
open appendicectomy,0,1,0,0,0,1
ophtamesone,0,0,0,1,0,1
opt-in recruitment email,1,0,0,0,0,1
opt-out recruitment email,1,0,0,0,0,1
optical coherence tomography (oct),0,0,0,1,0,1
optical coherence tomography angiography,0,1,0,0,0,1
optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,0,1,0,0,0,1
or antiplatelet) before admission for covid19,0,1,0,0,0,1
or high dose lmwh),0,0,0,1,0,1
or mis-c exposure,0,0,0,1,0,1
"or psychotherapy, n=10)",1,0,0,0,0,1
oral,0,0,0,1,0,1
oral polio vaccine / information,0,0,1,0,0,1
orthopaedic surgical procedures,0,1,0,0,0,1
oseltamivir 75mg,0,0,0,1,0,1
osteosynthesis,0,1,0,0,0,1
other clinical symptoms,0,1,0,0,0,1
otilimab,0,0,0,1,0,1
oxaloacetate medical food,0,0,0,1,0,1
oxaloacetate medical food/dietary supplement,0,0,0,1,0,1
oxidative stress elisa kit,0,0,0,1,0,1
oxygen-ozone,0,0,0,1,0,1
oxygen hood,0,1,0,0,0,1
oxyhydrogen,0,0,0,1,0,1
ozanimod,0,0,0,1,0,1
ozone,0,0,0,1,0,1
p2et (caesalpinia spinosa extract),0,0,0,1,0,1
pacritinib,0,0,0,1,0,1
pamrevlumab,0,0,0,1,0,1
pandemic control measures,0,0,0,1,0,1
paraclinical examination,0,0,0,1,0,1
paraclinical test,0,0,0,1,0,1
part 1 - tl-895,0,0,0,1,0,1
part 2 - tl-895,0,0,0,1,0,1
partially hla-matched sars-covsts,0,0,0,1,0,1
passed infection of sars-cov-2,0,1,0,0,0,1
passive microwave radiometry,0,1,0,0,0,1
"patch, nicotine",0,0,0,1,0,1
"patch, placebo",0,0,0,1,0,1
patient-centred advice on telephone consultation in tb patients:,0,0,0,1,0,1
patient characteristics,0,1,0,0,0,1
patient sampling,0,0,0,1,0,1
patient with sar-cov-2 infection,0,0,0,1,0,1
patients,1,0,0,0,0,1
patients admitted to intensive care unit with sars-cov2,1,0,0,0,0,1
patients covid 19,0,0,0,1,0,1
patients received standard of care treatment during hospitalization,0,0,0,1,0,1
patients with the treatment agains covid19,0,0,0,1,0,1
pbmt,0,1,0,0,0,1
pbmt/smf,0,1,0,0,0,1
pcr/chest ct,0,1,0,0,0,1
pct,0,0,0,1,0,1
pct/serology,1,0,0,0,0,1
peep,0,0,0,1,0,1
peer resilience champion,1,0,0,0,0,1
peer support,0,0,1,0,0,1
pegylated interferon-î±2b,0,0,0,1,0,1
pembrolizumab,0,0,0,1,0,1
pemziviptadil (pb1046),1,0,0,0,0,1
pentoxifylline,1,0,0,0,0,1
pep flute,0,0,0,1,0,1
percutaneous coronary revascularization for stemi,1,0,0,0,0,1
performance evaluation,0,0,0,1,0,1
performance evaluation study of realdetect rt-pcr kit for covid-19 detection,0,0,0,1,0,1
performance of the test antigenic,0,0,0,1,0,1
performance of the test antigenic/test rt-pcr,0,0,0,1,0,1
performing ai algorithms on images,0,0,0,1,0,1
performing of lung ultrasound,0,0,0,1,0,1
peripheral venous ultrasound,0,0,0,1,0,1
personal freedom message,0,1,0,0,0,1
personal protective equipment,0,0,0,1,0,1
personal protective equipment from biological hazard,0,1,0,0,0,1
personal protective testing booth,1,0,0,0,0,1
personalized ambulatory training,0,0,0,1,0,1
personalized feedback,1,0,0,0,0,1
personalized health education,0,0,0,1,0,1
pet-ct of 18f-fdg,0,1,0,0,0,1
pf-07304814,0,0,0,1,0,1
phase 1,0,0,0,1,0,1
phase 2,0,0,0,1,0,1
philips lumify ultrasound system,0,0,0,1,0,1
phlebotomy,0,0,0,1,0,1
phobia questionairre,0,0,0,1,0,1
phone interviews,0,0,0,1,0,1
phq,0,0,0,1,0,1
phq-9 depression scale,0,0,0,1,0,1
phr160 spray,0,0,0,1,0,1
phsyiotherapy,0,0,0,1,0,1
physiological effects of awake prone position in covid 19 patients,0,0,0,1,0,1
phytomedicine,0,0,1,0,0,1
pilot a rapid sars-cov-2 testing strategy,0,0,1,0,0,1
pioglitazone,0,0,0,1,0,1
pioglitazone 30 mg,0,0,0,1,0,1
piperacillin,0,0,0,1,0,1
piperacillin/tazobactam,0,0,0,1,0,1
placebo-lde phase 2,0,0,0,1,0,1
placebo - phase i,1,0,0,0,0,1
placebo (methylcellulose) capsule,0,0,0,1,0,1
placebo hydroxychloroquine,0,0,0,1,0,1
placebo nitazoxanide,0,0,0,1,0,1
placebo patch,0,0,0,1,0,1
placebo ribavirin,0,0,0,1,0,1
placebo videos,1,0,0,0,0,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
placebo/control,0,0,0,1,0,1
plant polyphenol,0,0,0,1,0,1
plasma igg levels,1,0,0,0,0,1
"platelet count, platelet, mean platelet volume",0,0,0,1,0,1
"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",0,0,0,1,0,1
platelet distribution width in covid-19,0,0,0,1,0,1
"platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
plethysmography,0,0,0,1,0,1
plethysmography/dlco,0,0,0,1,0,1
plitidepsin,1,0,0,0,0,1
pln-74809,0,0,0,1,0,1
pneumococcal vaccine,0,0,0,1,0,1
point-of-care test for sars-cov-2,0,0,0,1,0,1
polio vaccine,0,0,1,0,0,1
polio vaccine/na-831,0,0,1,0,0,1
polyoxidonium,1,0,0,0,0,1
polysomnography,1,0,0,0,0,1
pool lamp,0,0,0,1,0,1
pool rt-pcr,0,0,0,1,0,1
poractant alfa,0,0,0,1,0,1
position,0,0,0,1,0,1
positive feedback,0,1,0,0,0,1
post-traumatic stress screening,0,0,0,1,0,1
post covid-19 functional satus scale,0,0,0,1,0,1
postpartum,0,0,1,0,0,1
postpartum anxiety scale scores,1,0,0,0,0,1
postpartum women under investigation for coronavirus/diagnosed with covid-19,0,0,1,0,0,1
postural positioning,0,0,0,1,0,1
povidone,0,0,0,1,0,1
power breathe,0,0,0,0,1,1
prazosin,0,0,0,1,0,1
pre-operative screening,0,0,0,1,0,1
predict admission of covid-19 patients to icu,1,0,0,0,0,1
"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1,0,0,0,0,1
prediction market,0,1,0,0,0,1
predictive factors for clinical response in patients with covid-19.,0,0,0,1,0,1
predictors adverse evolution,0,0,0,1,0,1
predictors of health care provide,0,0,0,1,0,1
prednisone tablet,0,0,0,1,0,1
pregnant women under investigation for coronavirus,0,0,1,0,0,1
pregnant women under investigation for coronavirus/diagnosed with covid-19,0,0,1,0,0,1
preservision areds formulation gel tabs,0,0,1,0,0,1
prevalence of covid-19,0,1,0,0,0,1
primary care,0,1,0,0,0,1
"primary care professionals reports of potential patient safety incidents, non-covid-19 related",0,0,0,1,0,1
primepro,0,1,0,0,0,1
"pro bnp , vitamin d",0,0,0,1,0,1
probiorinse,0,0,0,1,0,1
probiotics,0,0,0,1,0,1
problem-solving,0,0,0,1,0,1
problem-solving/relationship improvement intervention.,0,0,0,1,0,1
procalcitonin,0,0,0,1,0,1
progesterone,1,0,0,0,0,1
prognostic score,1,0,0,0,0,1
progressive cycling exercise test to exhaustion,0,1,0,0,0,1
prolastin,0,0,0,1,0,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,0,1,0,0,0,1
prolonged proned positioning,0,0,0,1,0,1
proper diet,0,0,0,1,0,1
prophylactic,0,0,0,1,0,1
prophylaxis,0,1,0,0,0,1
propofol,0,0,0,1,0,1
prospective chart review,0,0,1,0,0,1
prospective oberservational registry,0,0,0,1,0,1
protein supplementation,0,0,0,1,0,1
prototype,0,0,0,1,0,1
proxalutamide,0,0,0,1,0,1
psg,0,0,0,1,0,1
psqi,0,1,0,0,0,1
pss,0,0,0,1,0,1
psychoeducation,0,0,0,1,0,1
psychoeducational intervention,0,0,0,1,0,1
psychological stress,0,1,0,0,0,1
psychological stress/adaptation at work score (psas),0,1,0,0,0,1
psychological/behaviour change support,0,0,0,1,0,1
psychological/sociological interviews,1,0,0,0,0,1
psychotherapy,0,0,0,1,0,1
ptc299,0,0,0,1,0,1
ptsd,0,0,0,1,0,1
public health england gold standard,0,0,0,1,0,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,1,0,0,0,0,1
pulmonary function testing,0,0,0,1,0,1
pulmonary function tests,0,0,0,1,0,1
pulmonary physiotherapy techniques,0,1,0,0,0,1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),0,0,0,1,0,1
pulse oximetry,0,1,0,0,0,1
pwv,0,0,0,1,0,1
pyridostigmine bromide,0,0,0,1,0,1
q-nrg metobolic cart device,0,0,0,1,0,1
q spect-ct,0,0,0,1,0,1
q vest,0,0,1,0,0,1
qazcovid-inâ® - covid-19 inactivated vaccine,1,0,0,0,0,1
qrt-pcr,0,0,1,0,0,1
qrt-pcr/serology,0,0,1,0,0,1
quadramune(tm),0,0,0,1,0,1
qualitative assessments of mental health,0,0,0,1,0,1
qualitative interviews..,0,0,0,1,0,1
quality of life promotion,0,0,1,0,0,1
quality of life questionnaires,0,0,0,1,0,1
quality of live assessment,0,0,0,1,0,1
quantitative,0,0,0,1,0,1
quantitative analysis of anti-sars-cov-2-antibodies,0,1,0,0,0,1
quantitative analysis of sars-cov-2 antibodies,0,1,0,0,0,1
quantitative igg test,1,0,0,0,0,1
quantitative/qualitative assessments of mental health,0,0,0,1,0,1
quantra system,0,0,1,0,0,1
quercetin phytosome,0,0,0,1,0,1
questionaire,0,1,0,0,0,1
questionnaire : preparedness for caregiving scale,0,0,0,1,0,1
"questionnaire, phone call",0,0,0,1,0,1
questionnaire/interview,0,0,0,1,0,1
"quickly avalaible clinical, biological",1,0,0,0,0,1
quinine,0,0,0,1,0,1
quinquina-stevia,0,0,1,0,0,1
quinquina-stevia/azythromycin,0,0,1,0,0,1
r tablets,1,0,0,0,0,1
racial inequality highlighted,1,0,0,0,0,1
radiological lung involvement evolution,0,0,0,1,0,1
radiological variables?,1,0,0,0,0,1
"raman analysis of saliva, characterization of the raman database",0,0,0,1,0,1
"raman analysis of saliva, characterization of the raman database/building of the classification model",0,0,0,1,0,1
ramipril,0,0,1,0,0,1
rapid-3,0,0,0,1,0,1
rapid diagnostic test vs pcr,0,0,0,1,0,1
rapid molecular test,0,0,0,1,0,1
rapid salivary test,0,1,0,0,0,1
rarefaction,0,0,0,1,0,1
rayaldee 30mcg extended-release (er) capsule,0,0,0,1,0,1
razuprotafib,0,0,0,1,0,1
razuprotafib subcutaneous solution,0,0,0,1,0,1
rbt-9 (90 mg),0,0,0,1,0,1
rdv,0,0,0,1,0,1
reactivity,0,0,0,1,0,1
reading a book,0,0,0,1,0,1
recharge,0,0,0,1,0,1
recombinant human interferon î±2b spray,1,0,0,0,0,1
recombinant human plasma gelsolin (rhu-pgsn),0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,0,0,0,1,0,1
recombinase,0,0,0,1,0,1
rectal swab,0,0,0,1,0,1
referral card,0,0,0,1,0,1
reginmune,0,0,0,1,0,1
registery data collection,0,0,0,1,0,1
regular care,0,0,0,1,0,1
regularly during follow up).,0,0,0,1,0,1
rehabilitation,0,1,0,0,0,1
rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
relation between frailty,0,0,0,1,0,1
relation between frailty/clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
relationship improvement intervention.,0,0,0,1,0,1
remain covid free ssi,0,1,0,0,0,1
remdesivir-hu,1,0,0,0,0,1
remestemcel-l,0,0,0,1,0,1
remote cognitive behavioral therapy for insomnia,0,0,0,1,0,1
remote controlled exercise,0,0,0,1,0,1
remote pulmonary rehabilitation,0,0,0,1,0,1
removal of dead space filter,0,0,0,1,0,1
renin-angiotensin system inhibitors,0,0,0,1,0,1
repeat sars-cov-2 igg antibodies at 45-65 days,0,1,0,0,0,1
"reporting of anosmia, ageusia",0,1,0,0,0,1
"reporting of anosmia, ageusia/other clinical symptoms",0,1,0,0,0,1
reprocessing recent traumatic event protocol,0,0,0,1,0,1
research specific blood sample,0,0,0,1,0,1
"resp301, a nitric oxide generating solution",0,0,0,1,0,1
respiratory function rehabilitation training,0,0,0,1,0,1
respiratory mechanics measurement,0,1,0,0,0,1
respiratory monitor,0,0,0,1,0,1
respiratory physiotherapy,0,0,0,1,0,1
respiratory rehabilitation,0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety",0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",0,0,0,1,0,1
respiratory tract sample,0,0,0,1,0,1
respiratory training,0,0,0,1,0,1
resting 12 lead ecg,0,0,0,1,0,1
resveratrol,0,0,0,1,0,1
retrospective,0,0,0,1,0,1
retrospective case-control analysis,0,1,0,0,0,1
retrospective metagenomics on clinical samples collected during hospitalization,1,0,0,0,0,1
reverse transcription polymerase chain reaction,0,1,0,0,0,1
rh-dnase,0,0,0,1,0,1
rhace2,0,0,0,1,0,1
rhinopharyngeal,0,1,0,0,0,1
rhtpo,0,0,0,1,0,1
ria-device (remote investigation,0,0,0,1,0,1
ria-device (remote investigation/assessment),0,0,0,1,0,1
right lateral decubitus),0,0,0,1,0,1
rintatolimod,0,0,0,1,0,1
risankizumab,0,0,0,1,0,1
risk factors,0,1,0,0,0,1
ritonavir 50 mg [kaletra],1,0,0,0,0,1
ritonavir/oseltamivir,0,0,0,1,0,1
roactemra,0,0,0,0,1,1
robot assisted percutaneous cardiovascular intervention,0,0,0,1,0,1
rosuvastatin,0,0,0,1,0,1
routine care (no sars-covsts),0,0,0,1,0,1
rph-104,0,1,0,0,0,1
rt-qpcr test,0,0,0,1,0,1
sab-185,0,0,0,1,0,1
saline-sodium citrate (ssc) buffer,0,0,0,1,0,1
saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,0,1,0,0,0,1
saline placebo boost,0,0,0,1,0,1
saline with baby shampoo nasal irrigation,1,0,0,0,0,1
saline/standard care,0,0,0,1,0,1
saliva assay,0,0,1,0,0,1
saliva based assay: crude rna extraction,0,0,0,1,0,1
saliva test kit,0,0,0,1,0,1
saliva.,0,0,1,0,0,1
saliva/nps test,0,0,0,1,0,1
salivary,0,1,0,0,0,1
samba ii,0,0,0,1,0,1
sample,0,0,0,1,0,1
sample collection/performance evaluation (a),0,0,0,1,0,1
sample collection/performance evaluation (b),0,0,0,1,0,1
sampler skills,0,0,0,1,0,1
sar443122,0,1,0,0,0,1
sars-cov-2-test,0,0,0,1,0,1
sars-cov-2 ab,0,1,0,0,0,1
sars-cov-2 and,0,0,0,1,0,1
sars-cov-2 and/or mis-c exposure,0,0,0,1,0,1
sars-cov-2 antibody analysis,0,0,1,0,0,1
sars-cov-2 antibody based ivig therapy,0,0,0,1,0,1
sars-cov-2 antibody immunoassays,1,0,0,0,0,1
sars-cov-2 antibody testing,0,0,0,1,0,1
sars-cov-2 igg,0,0,0,1,0,1
sars-cov-2 infection,1,0,0,0,0,1
sars-cov-2 rapid diagnostic test (covid-prestoâ® igm,0,0,0,1,0,1
"sars-cov-2 rapid diagnostic test (covid-prestoâ® igm/igg, aaz, boulogne-billancourt, france)",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",0,0,0,1,0,1
sars-cov-2 rs/matrix m1-adjuvant,0,0,0,1,0,1
sars-cov-2 s1,0,1,0,0,0,1
sars-cov-2 s1/s2 igg,0,1,0,0,0,1
sars-cov-2 serological assessment (igg),0,0,0,1,0,1
sars-cov-2 specific t cells,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 without adjuvant,1,0,0,0,0,1
sars-cov2 infection,0,0,0,1,0,1
sars-cov2 testing,0,0,0,1,0,1
satisfaction evaluation,0,0,0,1,0,1
savr,1,0,0,0,0,1
sbi-101,0,0,0,1,0,1
scanning chest x-rays/performing ai algorithms on images,0,0,0,1,0,1
scb-2019,0,0,0,1,0,1
scb-2019 with as03 adjuvant,0,0,0,1,0,1
scb-2019 with cpg 1018 adjuvant,0,0,0,1,0,1
scb-2019 with cpg 1018 adjuvant/alum adjuvant,0,0,0,1,0,1
scd,0,0,0,1,0,1
sch intervention,0,0,1,0,0,1
scta01,0,0,0,1,0,1
sedation,0,0,0,1,0,1
self-administered questionnaire,0,1,0,0,0,1
self-care tools,0,0,1,0,0,1
self-compassion for chronic pain virtual group treatment program,0,0,0,1,0,1
self-help booklet,1,0,0,0,0,1
self-interest message,0,1,0,0,0,1
self-management booklet (switch: stay well during covid-19),0,0,0,1,0,1
self-questionnary,0,0,0,1,0,1
self-reported symptom collection,0,0,0,1,0,1
self study,0,0,0,1,0,1
selinexor,0,0,0,1,0,1
semen analysis,0,1,0,0,0,1
semen qualitative analysis,1,0,0,0,0,1
semi-structured telephone questionnaire,0,0,0,1,0,1
sending thorax ct video images via smartphone applications,0,1,0,0,0,1
senicapoc,0,0,0,1,0,1
sequencing,0,0,0,1,0,1
seraph,0,0,0,1,0,1
seraphâ®-100 microbindâ® affinity blood filter,0,0,0,1,0,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,0,0,0,1,0,1
serologic assays for antibodies to sars-cov-2,0,0,0,1,0,1
serologic immunoassays to sars-cov-2 antibodies,0,0,0,1,0,1
serology test follow-up,1,0,0,0,0,1
serology test for covid-19,0,0,0,1,0,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,0,0,0,1,0,1
serum,1,0,0,0,0,1
serum neurofilaments as a marker of neurological damage.,0,0,0,1,0,1
serum neutralization,0,0,0,1,0,1
serum ngal,0,0,0,1,0,1
serum ngal/cystatin c,0,0,0,1,0,1
serum protein level analysis,0,1,0,0,0,1
service of questionnaire,0,1,0,0,0,1
sessions,1,0,0,0,0,1
severe acute respiratory syndrome coronavirus 2 detection,1,0,0,0,0,1
severity of lung involvement with covid-19.,0,1,0,0,0,1
shanshamani vati plus,0,1,0,0,0,1
shared decision making,0,0,1,0,0,1
shg,1,0,0,0,0,1
"shingrix (zoster vaccine recombinant, adjuvanted)",0,0,0,1,0,1
sildenafil,0,0,0,1,0,1
sildenafil citrate,0,0,0,1,0,1
silymarin,0,0,0,1,0,1
simha kriya,0,0,0,1,0,1
simple chest tomography,0,1,0,0,0,1
simulation of repurposed drugs for covid-19,1,0,0,0,0,1
simvastatin,0,0,0,1,0,1
single passive leg movement,0,0,0,1,0,1
sirukumab,0,0,0,1,0,1
six-minute walk test (6mwt),0,0,0,1,0,1
sledd with a l-mod,0,0,0,1,0,1
smartphone-based voice,0,0,0,1,0,1
smartphone-based voice/self-reported symptom collection,0,0,0,1,0,1
smf,0,1,0,0,0,1
sms-based support,0,0,0,1,0,1
sms message support,1,0,0,0,0,1
sng001,0,0,0,1,0,1
soc / ifx-1,0,0,0,1,0,1
soc / intravenous famotidine,0,0,0,1,0,1
social distancing,0,1,0,0,0,1
social media,0,1,0,0,0,1
social media campaigns encouraging cancer screening.,0,0,0,1,0,1
social media/news consumption,0,1,0,0,0,1
socialization,0,0,0,1,0,1
sofosbuvir/daclatasvir,0,0,0,1,0,1
soluble urokinase plasminogen activator receptor,0,0,0,1,0,1
solution-focused support program,0,0,0,1,0,1
sonclot coagulation,0,1,0,0,0,1
"sonclot coagulation/platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
SOP,0,0,0,1,0,1
sorbitol,0,0,0,1,0,1
spartan covid-19 system,0,1,0,0,0,1
spartan covid-19 test,0,0,0,1,0,1
specific anti-sars-cov-2 antibodies,0,0,0,1,0,1
specific exercise rehabilitation treatment,0,0,0,1,0,1
specimen collection,0,0,0,1,0,1
speed of processing training,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,0,0,0,1,0,1
spin-chat program,0,1,0,0,0,1
"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",0,0,1,0,0,1
spironolactone 25 mg pillules oral use,0,0,0,1,0,1
sse educational intervention,1,0,0,0,0,1
st. george's respiratory questionnaire (sgrq),0,0,0,1,0,1
staff wellbeing centres,0,0,0,1,0,1
standard care/placebo,0,0,0,1,0,1
standard interface,0,1,0,0,0,1
standard of care thromboprophylaxis,0,0,0,1,0,1
standard oxygen delivery system,0,0,0,1,0,1
standard prophylactic dose enoxaparin,0,0,0,1,0,1
standard prophylactic dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
standard therapy protocol (stp),0,0,0,1,0,1
statins,1,0,0,0,0,1
stc-19,0,1,0,0,0,1
stellate ganglion block,0,0,0,1,0,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,0,0,0,1,0,1
stools,0,0,0,1,0,1
stop processing,0,0,0,1,0,1
stp,0,0,0,1,0,1
stp / covid-19 convalescent plasma (cp),0,0,0,1,0,1
stp / standard plasma (sp),0,0,0,1,0,1
stress,0,0,0,1,0,1
stress scale,0,0,0,1,0,1
stress/anxiety questionnaire,0,0,0,1,0,1
study a,0,0,0,1,0,1
study arm,0,0,0,1,0,1
study b,0,0,0,1,0,1
study c,0,0,0,1,0,1
study d,0,0,0,1,0,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,0,0,0,1,0,1
subacute rehabilitation,0,0,0,1,0,1
sublingual methylene blue,0,0,0,1,0,1
sudarshan kriya yoga (sky),0,0,0,1,0,1
sulfur hexafluoride lipid-type a microspheres,0,0,0,1,0,1
sulodexide,0,1,0,0,0,1
supine position,0,0,0,1,0,1
supine positioning,0,0,0,1,0,1
supportive therapy ssi,0,0,0,1,0,1
supportive tratment,0,0,0,1,0,1
supportive/symptomatic treatment,1,0,0,0,0,1
surfactant,0,0,0,1,0,1
surge capacity,0,1,0,0,0,1
surgery,0,0,0,1,0,1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",0,1,0,0,0,1
surgical facial mask,0,1,0,0,0,1
surgical mask,0,0,0,1,0,1
surgical procedures performed under general anesthesia,0,1,0,0,0,1
survey/questionnaire,1,0,0,0,0,1
surveys/questionnaires,0,1,0,0,0,1
susceptibility to infection,0,0,0,1,0,1
suspension,0,0,0,1,0,1
suspension of heat killed (autoclaved) mycobacterium w,0,0,0,1,0,1
suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,0,0,0,1,0,1
swab,0,0,0,1,0,1
swallowing evaluation with the eat-10,0,0,0,1,0,1
swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),0,0,0,1,0,1
sweat samples (covidog ancillary study),0,0,0,1,0,1
symbicort,0,0,0,1,0,1
symptom,1,0,0,0,0,1
symptom/exposure surveys,1,0,0,0,0,1
symptomatic drugs,0,0,0,1,0,1
symptomatic treatment,1,0,0,0,0,1
symptomatic treatment (paracetamol,0,0,0,1,0,1
symptomatic treatment (paracetamol),0,0,0,1,0,1
symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
"symptomatology, treatment. daily activities",0,0,0,1,0,1
symptoms,0,0,0,1,0,1
synthetic neutralising antibodies,0,0,0,1,0,1
systemic,0,0,0,1,0,1
t cell derived exosom,1,0,0,0,0,1
t memory cells,0,0,0,1,0,1
t memory cells/nk cells,0,0,0,1,0,1
t3 solution,0,0,0,1,0,1
tacrolimus,0,0,0,1,0,1
taking biological samples,0,0,0,1,0,1
tape-software,0,0,0,1,0,1
taste/olfactory function evaluation,0,0,0,1,0,1
tavr,1,0,0,0,0,1
tavr/savr,1,0,0,0,0,1
tazobactam,0,0,0,1,0,1
tcc-covid mhealth,0,0,0,1,0,1
tcm,0,1,0,0,0,1
td139,0,0,0,1,0,1
tears swab,0,1,0,0,0,1
technology based social interactions,0,0,1,0,0,1
tele-interventions related to diabetes management,0,1,0,0,0,1
tele-interventions related to diabetes management/mental well-being,0,1,0,0,0,1
teleconsultation,1,0,0,0,0,1
teleconsultation either by phone,0,1,0,0,0,1
teleconsultation either by phone/by computer consultation,0,1,0,0,0,1
telehealth monitoring,0,0,0,1,0,1
telehealth/counselling,1,0,0,0,0,1
telephone consult,0,0,0,1,0,1
telephone follow-up,0,0,0,1,0,1
telephone interview,1,0,0,0,0,1
telepsychoeducation,0,0,1,0,0,1
telepsychoeducation with personalized videos,0,0,1,0,0,1
telepsychoeducation without personalized videos,0,0,1,0,0,1
telesimulation,0,0,0,1,0,1
tem-tpa,0,0,0,1,0,1
tenecteplase,0,0,0,1,0,1
tenofovir,0,0,0,1,0,1
tenofovir disoproxil,0,0,0,1,0,1
test,0,0,0,1,0,1
test group: experimental - uvc therapy applied,1,0,0,0,0,1
test rt-pcr,0,0,0,1,0,1
tested for sars-cov-2 (regardless of the result),0,0,0,1,0,1
testing,0,0,0,1,0,1
testing for sars-cov-2,1,0,0,0,0,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,0,1,0,0,0,1
tetrandrine,0,0,1,0,0,1
"the demographic, clinical, laboratory,",0,0,0,1,0,1
"the demographic, clinical, laboratory,/instrumental data",0,0,0,1,0,1
the management of severe covid-19 cases,0,0,0,1,0,1
the placenta,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
therapeutic exercise,0,0,1,0,0,1
therapeutic exercise/education,0,0,1,0,0,1
theraputic heparin,0,0,0,1,0,1
therapy intervention,0,0,0,1,0,1
there is no intervention in this study,0,0,0,1,0,1
thoracic ct,0,0,0,1,0,1
thoracic ct-scan,0,0,0,1,0,1
thoracic lung ultrasound,0,0,0,1,0,1
thoraxic computed tomography,0,0,0,1,0,1
three dose regimen,0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",0,0,0,1,0,1
throat swab sample for measuring current infection with sars-cov-2,0,0,0,1,0,1
thrombin,0,0,0,1,0,1
thromboprofylaxis protocol,0,1,0,0,0,1
thymalfasin,0,0,0,1,0,1
thymosin,0,0,0,1,0,1
thyroidectomy,0,1,0,0,0,1
tigeraseâ®,0,1,0,0,0,1
tigeraseâ®/best available care,0,1,0,0,0,1
tirofiban,0,1,0,0,0,1
titanium blood test,0,0,0,1,0,1
tj003234,0,0,0,1,0,1
tlrs activation measurement,0,0,0,1,0,1
tm5614,0,0,0,1,0,1
tnkase,1,0,0,0,0,1
tociliuzumab,0,1,0,0,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,0,0,0,1,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
tof protocol,0,1,0,0,0,1
tomography angiography,0,1,0,0,0,1
tracheostomy,0,0,0,1,0,1
tracheostomy with aerosol box in covid-19 positive patients,0,1,0,0,0,1
tracheotomy,0,0,0,1,0,1
tradipitant,0,0,1,0,0,1
traditional proning arm,0,0,0,1,0,1
training clinicians in basic critical care,0,0,0,1,0,1
training clinicians in basic critical care/the management of severe covid-19 cases,0,0,0,1,0,1
"training for awareness, resilience,",0,1,0,0,0,1
"training for awareness, resilience,/action (tara)",0,1,0,0,0,1
training load,1,0,0,0,0,1
"training of youth, community health assistants",0,0,0,1,0,1
"training of youth, community health assistants/community health workers.",0,0,0,1,0,1
training session adressing information,0,0,0,1,0,1
training session adressing information/health literacy,0,0,0,1,0,1
tranexamic acid,0,0,0,1,0,1
trans sodium crocetinate,0,0,0,1,0,1
transcutaneous auricular vagus nerve stimulation,0,0,0,1,0,1
transfer package from ci therapy,0,0,0,1,0,1
transfusion of sars-cov-2 convalescent plasma.,0,0,0,1,0,1
transfusion of standard plasma.,0,0,0,1,0,1
transplant patient,1,0,0,0,0,1
transpulmonary pressure measurements,0,0,0,1,0,1
transpulmonary thermodilution,0,0,0,1,0,1
trauma-informed yoga video recording,0,0,0,1,0,1
trauma informed psychotherapy,0,0,0,1,0,1
trauma informed yoga,0,0,0,1,0,1
travelan otc,1,0,0,0,0,1
treamid,1,0,0,0,0,1
treated with hyperimmune plasma,0,0,0,1,0,1
treatment,0,1,0,0,0,1
treatment for covid-19,0,0,0,1,0,1
treatment/prophylaxis,0,1,0,0,0,1
triazavirin (riamilovir),0,0,0,1,0,1
tridecactide,1,0,0,0,0,1
trier social stress test,0,0,0,1,0,1
trimodulin,0,0,0,1,0,1
trimoxazole,0,0,0,1,0,1
trust in science message,0,1,0,0,0,1
trv027,0,0,0,1,0,1
tsvf,0,0,0,1,0,1
tuberculin,0,0,0,1,0,1
turkish physicians,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083) administrations - high dose,0,0,0,1,0,1
two covid-19 vaccine candidate (tmv-083) administrations - low dose,0,0,0,1,0,1
two dose menacwy vaccine min. 4 weeks apart,0,0,0,1,0,1
two dose regimen,0,0,0,1,0,1
"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,0,0,1,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #high-dose group#",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",0,0,0,1,0,1
txa127,0,0,0,1,0,1
ty027,1,0,0,0,0,1
ub-612,0,0,0,1,0,1
ultra-micronized palmitoylethanolamide (mpea,0,0,0,1,0,1
ultra brief online mindfulness-based intervention,0,1,0,0,0,1
umifenovir,0,0,1,0,0,1
"umpea, 300mg",0,0,0,1,0,1
unavailable covid test result - hypothetical scenario,0,1,0,0,0,1
unfractionated heparin iv,0,0,0,1,0,1
unfractionated heparin sc,0,0,0,1,0,1
uni911 inhalation,0,0,0,1,0,1
unified protocol for covid-19 parenting stress (up-covid),1,0,0,0,0,1
unsupervised physical activities,0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load",0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load/metabolomic",0,0,0,1,0,1
usability,0,0,0,1,0,1
use,0,1,0,0,0,1
use of social media during covid-19,0,1,0,0,0,1
"use of the pinpointiq solution (physiq, inc.)",0,0,1,0,0,1
use/exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
usual antibiotic treatment,0,0,0,1,0,1
usual care positioning with no instructions,1,0,0,0,0,1
usual practice / symbicort rapihaler,0,0,0,1,0,1
utooth btc),0,0,0,1,0,1
uttr1147a,0,0,0,1,0,1
uv light treatment,0,0,0,1,0,1
v-sars,1,0,0,0,0,1
v/q spect-ct,0,0,0,1,0,1
v/q vest,0,0,1,0,0,1
v590,0,0,0,1,0,1
v591,0,0,0,1,0,1
vaccinated with polio vaccine (ipv),0,0,0,1,0,1
vaccine therapy,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,0,0,0,1,0,1
vadadustat,0,0,0,1,0,1
validation of the lamp assays,0,0,0,1,0,1
validation of the ngs method,0,0,0,1,0,1
validation of the poct antigen tests,0,0,0,1,0,1
vcpm,0,0,0,1,0,1
vehicle,0,1,0,0,0,1
vehicle / heparin along with best supportive care,0,1,0,0,0,1
vehicle control,0,0,0,1,0,1
venipuncture in peripheral vein,0,0,0,1,0,1
venous draw,0,0,0,1,0,1
venous draw/testing,0,0,0,1,0,1
verapamil,0,0,0,1,0,1
veru-111,0,0,0,1,0,1
vib7734,0,0,0,1,0,1
vibrolung,0,0,0,1,0,1
video-based intervention,0,0,0,1,0,1
video chat,1,0,0,0,0,1
video chat / basic feedback,1,0,0,0,0,1
video chat /personalized feedback,1,0,0,0,0,1
video dance classes,0,0,0,1,0,1
videofluoroscopy,0,0,0,1,0,1
vielight rx plus,0,0,0,1,0,1
views,0,0,0,1,0,1
vir-7831,0,0,0,1,0,1
virgin coconut oil (vco),0,0,0,1,0,1
virtual care at home,0,0,0,1,0,1
virtual elm,1,0,0,0,0,1
virtual group exercise,0,0,0,1,0,1
virtual group intervention,0,1,0,0,0,1
virtual reality,0,0,0,1,0,1
virtual reality therapy first,1,0,0,0,0,1
viruxal oral,0,0,0,1,0,1
viruxal oral/nasal spray,0,0,0,1,0,1
visual prompts,0,1,0,0,0,1
vitamin b,0,0,0,1,0,1
vitamin c tablets,0,0,0,1,0,1
vitamin e,1,0,0,0,0,1
vitamins,0,0,0,1,0,1
vitros anti-sars-cov-2 igg test,0,0,1,0,0,1
viusid,0,0,0,1,0,1
viusid/asbrip,0,0,0,1,0,1
voice symptom scale (voiss),0,0,0,1,0,1
volume rapid test,0,0,0,1,0,1
vxa-cov2-1,1,0,0,0,0,1
walk test,0,0,0,1,0,1
water without an elevated level of kelea,0,0,0,1,0,1
wearing surgical face mask sprayed with hypertonic saline,0,0,0,1,0,1
web-based redcap survey,0,0,0,1,0,1
web application users,0,0,0,1,0,1
web based questionnaire,0,0,1,0,0,1
weck-cel swab collection,0,0,1,0,0,1
weekly assessment,0,0,0,1,0,1
white sender in acknowledgement,1,0,0,0,0,1
white sender in informational videos,1,0,0,0,0,1
who recommendations (waiting condition),0,0,0,1,0,1
whoqol-bref,0,0,0,1,0,1
withings scanwatch,0,0,0,1,0,1
woebot substance use disorder,0,0,0,1,0,1
written summary of rounds,0,0,0,1,0,1
x-ray,0,0,0,1,0,1
xav-19,0,0,0,1,0,1
xc221,0,1,0,0,0,1
xcel-umc-beta,0,0,0,1,0,1
yoga group,1,0,0,0,0,1
zanubrutinib,0,0,0,1,0,1
zaritt burden interview,0,0,0,1,0,1
zavegepant (bhv-3500),0,0,0,1,0,1
zidovudine,0,1,0,0,0,1
zilucoplanâ®,0,0,0,1,0,1
zinc citrate,0,0,0,1,0,1
zinc picolinate,0,0,0,1,0,1
zithromax,0,0,0,1,0,1
zofin,0,0,0,1,0,1
